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ABSTRACT 
 
Atherosclerotic vascular diseases (ASVDs) affect the heart and circulatory system. One of 
the most common forms is coronary artery disease (CAD) which may eventually lead to 
acute coronary syndrome (ACS). ASVDs are currently the leading cause of mortality 
worldwide, and account for 47% of all deaths in Europe. The underlying mechanism is 
atherosclerosis, a progressive disease that manifests in several tissues. Common chronic 
infections, including periodontal disease and Chlamydia pneumoniae, may promote 
atherosclerosis and are associated with an increased risk of ASVDs.  
 The general aims of this thesis project were to investigate the role of bacteria 
associated with periodontal disease in CAD, and the mechanisms by which common 
chronic infections promote proatherogenic alterations. More specifically, we aimed to: I) 
study the effects of Aggregatibacter actinomycetemcomitans and C. pneumoniae 
infections on the liver and adipose tissue lipid homeostasis and inflammation status in 
mice; II) develop and validate a quantitative PCR (QPCR) method to analyze the levels of 
periodontal disease-associated bacteria in saliva; and III) determine the association 
between salivary pathogen levels and CAD.  
 The animal studies were conducted in atherosclerosis-susceptible apolipoprotein 
E-deficient mice. They were infected intravenously with viable A. actinomycetemcomitans 
and intranasally with viable C. pneumoniae. Consequently, the pathogens were recovered 
in the liver and C. pneumonia also in the lungs. Both infections induced systemic and 
hepatic inflammation, which were seen as an elevation of inflammation markers. Chronic 
C. pneumoniae infection induced hepatic microvesicular formations, which may promote 
steatosis. The recurrent A. actinomycetemcomitans infection disturbed the lipid 
homeostasis of adipose tissue: the proportion of saturated fatty acids was increased and 
that of polyunsaturated fatty acid decreased. The alterations in adipose tissue 
transcriptomes were depot-specific, and the inguinal adipose tissue was especially prone 
to inflammation-related responses.  
 Single-copy gene-based QPCR assays were developed for five periodontal 
disease-associated bacteria: A. actinomycetemcomitans, Porphyromonas gingivalis, 
Prevotella intermedia, Treponema denticola, and Tannerella forsythia. The assays were 
validated in a case-control population including periodontally diseased and healthy 
subjects, and the diagnostic ability was found to be potent. The association of these 
pathogens with CAD was determined by analyzing saliva samples from the Parogene 
cohort (n = 492), consisting of patients with stable CAD, ACS, and no significant CAD as the 
reference group. All CAD diagnoses were verified by coronary angiography. The increased 
salivary levels of A. actinomycetemcomitans strongly associated with both stable CAD and 
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ACS. Systemic exposure to the pathogen was seen as elevated serum antibody levels 
against the pathogen.  
 The findings from the animal study indicate that A. actinomycetemcomitans and C. 
pneumoniae infections induce inflammation and disturbances in lipid and fatty acid 
homeostasis in the liver and adipose tissue. The potential tissue dysfunction may further 
augment the progression of atherosclerosis. The results from the Parogene study 
demonstrate that high salivary levels and systemic exposure to A. actinomycetemcomitans 
are associated with the risk of CAD and its acute manifestation. The findings from the 
thesis study are of common interest, because the studied pathogens are highly prevalent 
among the general population and their persistence may increase the overall risk of ASVDs. 
 
Keywords: Aggregatibacter actinomycetemcomitans, Chlamydia pneumoniae, coronary 
artery disease, periodontal disease, periodontal pathogen, apoE-deficient mice 
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1. REVIEW OF THE LITERATURE 
 
1.1. Atherosclerosis: inflammatory background 
 
Atherosclerotic vascular diseases (ASVDs) affect the heart and circulatory system, and 
comprise ischemic heart disease, cerebrovascular disease, and peripheral vascular disease. 
The ASVDs are chronic and progress over many years. The most common forms are 
coronary artery disease (CAD) and cerebrovascular disease, which may eventually lead to 
adverse outcomes, such as acute coronary syndrome (ACS) and stroke. ASVDs are 
currently the leading cause of mortality worldwide. In 2010, the prevalence of ASVD was 
35% among the adult population in the United States (Go et al. 2013). In Europe, 47% of 
all deaths are caused by them (http://www.ehnheart.org/cvd-statistics.html). The 
underlying mechanism is atherosclerosis, a slow, progressive disease that manifests in 
large and medium-sized arteries as hardening and stenosis. Atherosclerosis has a complex, 
multifactorial pathophysiology, which may be initiated by injury in the vascular 
endothelium. Subsequent inflammation of the vessel wall has a key role in atherosclerosis 
and is present throughout all stages of the disease.  
 
1.1.1. Overview of lipoprotein metabolism and lipid transport 
 
Regarding atherosclerosis, the most important plasma lipids are cholesterol and 
triglycerides (TGs). Due to their water-insoluble character, the transportation of these 
essential molecules in the circulation requires amphipathic lipoproteins. These are water-
soluble molecular complexes containing a hydrophilic coat of apolipoproteins (apo), free 
cholesterol, and phospholipids, and a hydrophobic core formed by cholesteryl esters (CEs) 
and TGs. The major lipoprotein classes are chylomicrons, very low-density lipoproteins 
(VLDLs), intermediate-density lipoproteins (IDLs), low-density lipoproteins (LDLs), and 
high-density lipoproteins (HDLs). They vary in size, physiological properties, and content: 
the main CE carriers are LDLs and HDLs, while TGs are predominantly transported by 
larger chylomicrons and VLDLs. (Gotto et al. 1986; Ginsberg 1990) 
 Dietary fats are emulsified in the intestine by bile acids and hydrolyzed by 
pancreatic lipase and cholesterol esterase into free fatty acids (FFAs), monoacylglycerols, 
and non-esterified cholesterol (Figure 1). After absorption by enterocytes, the TGs and CEs 
are re-produced and the TGs are assembled into chylomicrons with phospholipids, CEs, 
free cholesterol, and apolipoproteins, particularly apoB-48. Chylomicrons are secreted 
into the subclavian vein via the thoracic duct and delivered to peripheral tissues. During 
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fasting, when lipid levels are too low for chylomicron formation, the intestine secretes 
VLDLs. (Mu and Hoy 2004; Williams 2008) Lipoprotein lipase (LPL) bound to the 
endothelial surface of capillaries hydrolyzes the chylomicron and VLDL core TGs into FFAs, 
which are partly taken up by muscle and adipose tissue (AT) and used as an energy source 
(Oscai et al. 1990; Olivecrona et al. 1997). In adipocytes, acyl-CoA:diacylglycerol 
acyltransferase (DGAT) re-synthesizes excess FFAs into TGs for storage (Cases et al. 1998). 
On energy demand, these TGs are re-hydrolyzed by hormone-sensitive lipase (HSL) and 
adipose TG lipase (Schweiger et al. 2006; Bezaire et al. 2009). The FFAs in circulation are 
tightly bound to albumin. The hydrolysis of chylomicrons forms TG-depleted chylomicron 
remnants, which are subsequently internalized by hepatic LDL receptor (LDLR) or LDLR-
related protein through binding to heparan sulfate proteoglycans and apoE (Mahley and Ji 
1999; Williams 2008).  
 
 
Figure 1. Overview of lipoprotein metabolism. (Rader and Daugherty 2008) Reprinted with 
permission from Nature Publishing Group. 
 
 Approximately 80% of the circulating cholesterol derives from endogenous 
synthesis, and the predominant lipid-synthesizing organ in humans is the liver. Lipids from 
both chylomicron remnants and hepatic de novo synthesis are assembled into VLDL 
particles with various apolipoproteins, particularly apoB-100 (Figure 1). VLDLs are 
secreted into the circulation and hydrolyzed by lipoprotein lipase releasing FFAs and IDLs, 
and furthermore by hepatic lipase yielding LDL particles. (Santamarina-Fojo et al. 2004; 
Dallinga-Thie et al. 2010; Tiwari and Siddiqi 2012) LDLs are enriched with cholesterol and 
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serve as a major sterol pool for peripheral tissues for growth and hormone production. 
LDL particles are taken up via LDLR and the cells strictly control the cholesterol uptake 
levels by the expression and recycling of the LDLR (Goldstein and Brown 2009). However, 
macrophages may internalize cholesterol in an uncontrolled manner via scavenger 
receptors, which leads to the formation of cholesterol-rich foam cells (Greaves and 
Gordon 2005). In the liver, LDLs are degraded in the lysosomes and the released 
cholesterol is re-esterified or converted into bile acids for biliary secretion.  
 The transportation of excess cholesterol from peripheral cells and tissues to the 
liver is mainly facilitated by HDL particles. HDLs are generated by the intestine and liver via 
interactions between cholesterol, ATP-binding cassette transporter (ABC) A1, and apoA-I 
(Figure 1). Lipid-free apoA-I is lipidated via ABCA1 and forms nascent HDL. (Ragozin et al. 
2005; Lee and Parks 2005; Brunham et al. 2006) This discoidal HDL is rapidly converted 
into small spherical HDL by esterification of free cholesterol by lecithin cholesterol 
acyltransferase (LCAT), and these particles may fuse together creating mature HDLs. In the 
peripheral tissues, nascent HDLs promote the efflux of cholesterol via ABCA1 
(Vedhachalam et al. 2007); mature HDLs may mediate the efflux via ABCG1 and ABCG4 
(Wang et al. 2004). Activation of nuclear liver X receptor (LXR) increases the expression of 
ABCA1 and ABCG1 and thereby the efflux of cholesterol (Tangirala et al. 2002). HDL 
particles are a very heterogeneous population and the lipid content is constantly modified 
by lipases, cholesterol ester transfer protein (CETP), and phospholipid transfer protein 
(PLTP). HDLs may either donate lipids to other lipoproteins or carry them to the liver, 
where hepatocytes uptake HDL cholesterol via scavenger receptor B1 (SR-B1). (Krieger 
2001; Barter 2002)   
  
1.1.2. Pathogenesis of atherosclerosis 
 
Most of the arteries modified by obstructive atherosclerosis have the structure of 
muscular arteries. The intact vessel wall contains three separate layers: the intima, media, 
and adventitia. The innermost layer, the intima, is lined from blood flow by a monolayer of 
endothelial cells and contains connective tissue and resident smooth muscle cells (SMCs). 
It is separated from the media by an internal elastic lamina. The media is comprised of 
SMCs embedded in a complex extracellular matrix and is lined from the adventitia by an 
external elastic lamina. The outermost adventitia contains mast cells, fibroblasts, SMCs, 
connective tissue, nerve endings, and microvessels. (Libby et al. 2011) The intact artery 
endothelium resists the adherence of circulating leukocytes. However, when predisposed 
to irritating stimuli, such as hypertension, dyslipidemia, advanced glycation end-products, 
tobacco smoke, and microbial infection, the endothelium may become injured. The 
following dysfunction especially occurs in branching and arching sites of the artery and 
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leads to the expression of inducible adhesion molecules, including intercellular adhesion 
molecule 1 (ICAM-1) and vascular cell adhesion molecule 1 (VCAM-1). (Bevilacqua et al. 
1987; Gimbrone 2010) Subsequent adherence of monocytes to activated endothelium is 
followed by migration into the intima and maturation into macrophages. These steps are 
directed by chemokine and growth factor signals, particularly monocyte chemoattractant 
protein (MCP)-1 and monocyte colony-stimulating factor produced by activated 
endothelial cells and SMCs. (Ylä-Herttuala et al. 1991; Clinton et al. 1992) Parallel 
alterations in the permeability of the endothelial monolayer promote the entry of LDLs 
into the intima, and their subendothelial retention is facilitated by apoB-100 binding to 
extracellular matrix proteoglycans (Boren et al. 1998; Khalil et al. 2004; Gimbrone 2010). 
Retained LDL particles are subjected to various modifications, such as oxidation, 
aggregation, and proteolysis. Oxidation may be performed enzymatically by 
myeloperoxidase (MPO) and lipoxygenase or by reactive oxygen species (ROS). 
(Steinbrecher et al. 1984; Palinski et al. 1989; Parthasarathy et al. 1989; Savenkova et al. 
1994) Oxidized LDLs and released bioactive byproducts stimulate the endothelial cells to 
express diverse chemokines, adhesion molecules, and growth factors (Cushing et al. 1990; 
Rajavashisth et al. 1990; Amberger et al. 1997). This recruits more monocytes, dendritic 
cells, and T cells on site. Activated macrophages produce reactive oxygen and nitrogen 
species, MCP-1, tumor necrosis factor α (TNF- α), interleukin (IL)-1β, and IL-6, and amplify 
the inflammatory status in the intima. Aggregating modified LDLs are engulfed by 
macrophages via scavenger receptors, such as SR-A, CD36, and CD68, resulting in foam cell 
formation (Henriksen et al. 1983; Greaves and Gordon 2009). Accumulating foam cells 
evolve with SMCs and T cells into early atherosclerotic lesions, the fatty streaks (Figure 2) 
(Katsuda et al. 1992).        
 
 
Figure 2. Development of atherosclerosis. (Koenig and Khuseyinova 2007) Reprinted and 
modified with permission from Wolters Kluwer Health. 
 
 In addition to scavenger receptors, the cells in an atherosclerotic lesion may be 
activated via toll-like receptors (TLRs) (Edfeldt et al. 2002). These pattern-recognition 
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receptors (PRRs) recognize, for example, oxidized LDL, modified phospholipids, and 
pathogen-associated molecular patterns. Ligation in macrophages triggers intracellular 
signaling cascades via nuclear factor-κB (NF-κB) and activator protein 1 pathways, yielding 
the production of antimicrobial peptides and pro-inflammatory molecules, including 
cytokines, chemokines, eicosanoids, proteases, oxidases, and co-stimulatory molecules 
(Hansson and Hermansson 2011). Intracellular inflammasomes may be activated via 
cholesterol crystals and induce IL-1β secretion (Rajamäki et al. 2010). The predominant T 
cells in atherosclerotic lesions are T helper type 1 (TH1) which, after activation, sustain and 
magnify the inflammation by secreting interferon (INF)-γ (Frostegard et al. 1999). The TH1-
derived cellular response is considered as one of the major factors in the progression of 
atherosclerosis. INF-γ enhances the activation of vascular wall cells and macrophages, 
recruitment of T cells and monocytes, production of proteases and proinflammatory 
cytokines, and expression of major histocompatibility complex class II (Leon and 
Zuckerman 2005). A smaller population of regulatory T cells exerts anti-inflammatory 
actions by secreting IL-10 and transforming growth factor-β. The number of B cells in 
atherosclerotic lesions is relatively low. Nevertheless, B cells may accumulate and organize 
themselves in the adventitia with antigen presenting cells and develop into a tertiary 
lymphoid structure. (Andersson et al. 2010; Hansson and Hermansson 2011) However, 
atherogenesis may be promoted by innate and adaptive immune responses to 
autoantigens, particularly heat shock protein (hsp) 60 and modified LDL (Shoenfeld et al. 
2004; Grundtman et al. 2011).  
 The progression of atherosclerotic lesions involves the migration of SMCs from 
the media to the intima. Both resident intimal and media-derived SMCs proliferate, 
secrete large amounts of extracellular matrix components, such as proteoglycans, collagen, 
and elastin, and form a plaque-covering fibrous cap beneath the endothelial cells. This 
augments the accumulation and retention of atherogenic lipoproteins, the formation of 
foam cells and cholesterol crystals, activation of leukocytes, and thereby the growth of the 
lesion and chronic inflammation status (Figure 2). (Dzau et al. 2002) As the lesion evolves, 
aggregating foam cells eventually die and release their cellular debris and lipid content 
into the intima, thus forming a cholesterol-rich necrotic core (Ball et al. 1995; Seimon and 
Tabas 2009). Generally, the enlargement of the plaque manifests clinically as stenosis and 
tissue ischemia. Vulnerable plaques with thin fibrous caps and abundant inflammatory 
cells may also rupture and release thrombogenic material into the lumen (Thim et al. 
2008). The disruption is promoted by matrix metalloproteinases (MMPs) and cathepsins, 
which degrade the fibrous cap (Galis et al. 1994). Furthermore, lesion calcification and 
neovascularization, and activated mast cells may enhance the destabilization of the 
plaque (Lusis 2000; Lindstedt and Kovanen 2004). Interaction between thrombogenic 
material, including tissue factor, and activated platelets in the circulation enables 
thrombus formation, which may eventually block the blood flow and cause acute coronary 
and cerebrovascular events (Badimon et al. 2011).   
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1.1.3. Risk factors 
 
Several well-documented risk factors may contribute to the initiation and progression of 
atherosclerosis. The non-modifiable factors comprise male gender, aging, and a family 
history of premature atherosclerotic disease. The classical modifiable factors with a strong 
genetic background include a high level of serum total cholesterol, high level of serum LDL 
cholesterol, low level of serum HDL cholesterol, hypertension, diabetes mellitus, and 
obesity. The environmental risk factors are smoking, a high-fat diet, and inadequate 
physical exercise. The total risk for ASVDs is a complex combination of both genetic and 
environmental factors. In addition, the risk factor spectrum is continuously broadening 
and currently also includes elevated levels of serum TGs, TG-rich lipoproteins, C-reactive 
protein (CRP), lipoprotein-associated phospholipase A2, and lipoprotein(a), as well as  
impaired glucose tolerance and fasting glucose (Fruchart et al. 2004; Sudhir 2006; 
Enkhmaa et al. 2011). Metabolic syndrome, a varying combination of elevated TGs, a low 
level of serum HLD cholesterol, impaired fasting glucose, hypertension, and increased 
waist circumference or body mass index, is independently associated with an increased 
risk of coronary heart disease (CHD) and stroke (Wannamethee et al. 2005; McNeill et al. 
2005). Furthermore, the proatherogenic role of infectious microbes, including Chlamydia 
pneumoniae, Helicobacter pylori, Porphyromonas gingivalis, Aggregatibacter 
actinomycetemcomitans, cytomegalovirus, influenza A virus, hepatitis C virus, and human 
immunodeficiency virus, has been demonstrated in several studies (Rosenfeld and 
Campbell 2011). 
 
1.1.4. Apolipoprotein E-deficient mouse model 
 
Wild-type mice are relatively resistant to atherosclerosis due to the high level of serum 
HDL particles, which transport most of the cholesterol in the murine circulation. 
Consequently, the mouse models for atherosclerosis must have an altered lipoprotein 
metabolism to initiate the disease. The most widely used mouse model in atherosclerosis 
research is the apoE-deficient mouse (Piedrahita et al. 1992; Plump et al. 1992; Meir and 
Leitersdorf 2004; Vasquez et al. 2012). ApoE is a high affinity ligand for LDLR and LDLR-
related proteins, and is thus particularly important in the clearance of chylomicron 
remnants, VLDLs, and LDLs from the circulation by the liver. On a chow diet, homozygous 
apoE-deficient mice with a C57BL/6J or C57BL/6–BALB/c-hybrid genetic background have 
approximately 6-fold higher plasma cholesterol levels than wild-type mice. The levels of 
TGs are only moderately elevated. On a Western-type diet, the cholesterol levels are 10-
fold higher. In contrast to HDLs in the plasma of wild-type mice, the major plasma 
lipoprotein particles resemble VLDLs and, to a lesser extent, chylomicron remnants, IDLs, 
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and LDLs. (Zhang et al. 1992; Nakashima et al. 1994) ApoE-deficient mice also develop 
atherosclerotic lesions throughout the aorta on a chow diet, with the first lesions 
appearing at 10 weeks of age and detectable early fibrous plaques at 20 weeks of age. The 
lesions continue to progress and increase along with aging, and the development 
resembles the human disease. A Western-type diet accelerates the process and results in 
more severe lesions at all stages. (Nakashima et al. 1994) The advanced lesions in 
innominate arteries of older (aged 42 to 60 weeks) apoE-deficient mice show a similarity 
to vulnerable plaques in humans, including the formation of a necrotic core, the loss of 
the fibrous cap, and intraplaque hemorrhage (Rosenfeld et al. 2000). Even though isolated 
lipid-packed macrophages may frequently be found in the lumen, the plaque rupture and 
occlusive thrombi causing myocardial infarction (MI) remain absent in the apoE-deficient 
mouse model (Coleman et al. 2006). Under the influence of aging and a Western-type diet, 
apoE-deficient mice also exhibit endothelial dysfunction, hypertension, and tachycardia 
(Vasquez et al. 2012). It should be noted that the genetic background and gender greatly 
affect atherosclerosis-related phenomena, including serum lipid and lipoprotein profiles, 
atherosclerotic lesion diameters, and liver steatosis in apoE-deficient mice (Paigen et al. 
1987; Surra et al. 2010).  
 Chronic inflammation and the T cell response are important in the development 
of atherosclerosis in humans, and apoE has been shown to attenuate the inflammation. 
The T cells of apoE-deficient mice proliferate more prominently and secrete higher 
amounts of INF-γ than T cells from wild-type mice. Additionally, after INF-γ stimulation, 
the macrophages of apoE-deficient mice exhibit up-regulated expression of major 
histocompatibility complex class II and co-stimulating molecules CD80 and CD40 when 
compared to wild-type mice macrophages. (Tenger and Zhou 2003) ApoE-deficient mice 
have also been reported to have elevated levels of anti-tetanus toxoid IgM levels after 
immunization and a decreased delayed-type hypersensitivity response (Laskowitz et al. 
2000). Mice are generally rather resistant to endotoxemia (Copeland et al. 2005). In 
contrast, apoE-deficient mice show increased susceptibility to the deleterious effect of 
lipopolysaccharide (LPS): the endotoxemia-induced TNF-α response and lethality are 
increased, and the plasma LPS neutralizing capacity decreased (de Bont et al. 1999; Van 
Oosten et al. 2001). ApoE-deficient mice are also more vulnerable to Klebsiella 
pneumoniae infection (de Bont et al. 1999). 
 The levels of hepatic free cholesterol and TGs, and the presence of lipid droplets 
have been reported to be markedly elevated among apoE-deficient mice at 12 weeks of 
age. The activity and expression of hepatic HMG-CoA reductase declined, while biliary 
cholesterol secretion and bile acid synthesis remain unaltered. (Kuipers et al. 1996) The 
accumulation of lipids may be a consequence of the observed impaired TG and VLDL 
assembly and secretion (Kuipers et al. 1997; Mensenkamp et al. 2004). A systemic 
deficiency of apoE also affects adipocytes, which express apoE in abundant amounts 
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according to differentiation and the lipid content status (Zechner et al. 1991). ApoE-
deficient mice have less AT and smaller adipocytes than wild-type mice. Isolated AT 
contains decreased levels of FFAs and TGs, and the adipocytes exhibit reduced TG and 
cholesterol synthesis, increased TG hydrolysis and expression of fatty acid oxidation-
related genes, and decreased expression of adiponectin. (Huang et al. 2006) These 
observations may be partly explained by the impaired VLDL mediated AT lipogenesis in 
apoE-deficient mice (Huang et al. 2009). 
 
1.2. Proatherogenic disorders in the liver and adipose tissue 
 
Circulating FFAs are predominantly derived via adipose tissue lipolysis. In the basal state 
the FFAs are stored in adipocytes as TGs and mobilization back to the circulation is tightly 
controlled. However, prolonged excess energy intake and insulin resistance-derived 
disturbances in AT function may result in dysregulated lipolysis and the expression of 
adipokines, followed by an increased serum FFA concentration. Surplus FFAs are taken up 
by the liver. The liver and AT are very important in controlling whole-body metabolic 
homeostasis and are coupled together via a complex endocrine signaling system. 
Disturbances contribute to the development of hepatic steatosis, type 2 diabetes, and 
metabolic syndrome. These phenomena are closely associated with ASVDs and the 
progression of atherosclerosis.  
 
1.2.1. Adipose tissue lipid metabolism and dysfunction 
 
AT is a multi-functional organ involved in energy storage, endocrine homeostasis, and 
immune responses. It comprises a heterogeneous cell population including adipocytes and 
a stromal vascular fraction: macrophages, leukocytes, vascular cells, fibroblasts, and pre-
adipocytes. Adipocytes constitute approximately 90% of the tissue volume; however, the 
stromal vascular fraction dominates in cell numbers. The vast majority of human AT is 
white AT, and the depots are associated subcutaneously, viscerally, in bone marrow, and 
in breast tissue. The depots possess different physiological characteristics and regional 
variation in adipokine profiles, lipid metabolism, and the insulin response. (Ouchi et al. 
2011; Lee et al. 2012) 
 The long-term energy reserves of the body are stored in adipocytes as TGs, which 
may be derived via de novo lipogenesis or from serum via FFA uptake. The AT de novo 
lipogenesis pathway is relatively inactive in humans when compared to rats, which is 
probably due to lower levels of the lipogenesis-activating transcription factors sterol 
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regulatory element binding protein-1c (SREBP-1c) and carbohydrate responsive element 
binding protein (chREBP) (Letexier et al. 2003). The main source of FFAs is consequently 
the uptake of FFAs from TG-rich lipoproteins, mainly chylomicrons and VLDL. Lipolysis of 
lipoproteins is processed on the luminal side of capillaries by LPL with apo-CII as an 
important co-factor. LPL is anchored to capillary endothelial cells by heparin sulfate 
proteoglycans. (Saxena et al. 1990; Weinstock et al. 1997) FFAs may diffuse across 
membranes, but most of them are transported by fatty acid transport proteins (FATPs), 
especially FATP1 and 4, AT fatty acid binding protein (FABP), and scavenger receptor FT 
(fatty acid translocase)/CD36 (Coburn et al. 2000; Lobo et al. 2007). Esterification of FFAs 
includes the sequential addition of acyl-CoA to glycerol and the committed step, 
conversion of diacylglycerol (DAG) to TGs, is catalyzed by membrane-associated DGAT1 
and DGAT2 (Cases et al. 2001). In white AT adipocytes, the generated TGs are stored in 
large perilipin-coated lipid droplets (Blanchette-Mackie et al. 1995), which can vary in size 
from approximately 25 to 200 µm.  
 The hydrolysis of TGs is catalyzed by several lipases. HSL possesses TAG, DAG, and 
cholesterol hydrolase activities, whereas ATGL is limited to TAG. The final hydrolytic step is 
catalyzed by monoacyglycerol lipase. Upon stimulation, HSL is translocated to the lipid 
droplet surface. The decomposition of lipid droplets and TG hydrolysis is facilitated by 
perilipin phosphorylation and the binding of HSL to FATP4 (Smith et al. 2004; Miyoshi et al. 
2006). ATGL participates in basal lipolysis and is activated and stimulated by co-factor α/β 
hydrolase fold domain 5, which interacts with perilipin and ATGL (Schweiger et al. 2006). 
The exit of FFA from adipocytes is possibly mediated by FT/CD36 and FATP4. Insulin and 
activation of α2-adrenergic receptors are potent inhibitors of the lipolytic pathway. Insulin 
resistance down-regulates DGATs and fatty acid synthase, and up-regulates TG hydrolysis 
and the FATP-mediated transport of FFAs. In addition, lipolysis is activated by prolonged 
exposure to TNF-α and IL-6. (Lafontan 2008) 
 In addition to lipids, AT secretes various protein factors and signaling molecules 
termed adipokines. These include steroid hormones, growth factors, complement factors, 
vasoactive factors, cytokines, apoE, CETP, eicosanoids, adiponectin, leptin, apelin, visfatin, 
resistin, plasminogen activator inhibitor (PAI)-1, and chemerin (Hassan et al. 2012). 
Adipokines are important in controlling whole-body angiogenesis, blood pressure, glucose 
homeostasis, lipid metabolism, and vascular hemostasis. The accumulation of excess AT 
mass and increased insulin resistance, followed by AT dysfunction, result in the 
dysregulated secretion of adipokines (Ouchi et al. 2011). Adipocytes exhibit inflammatory 
properties and may be activated in parallel to resident macrophages by pathogens and 
inflammatory stimuli via TRLs and TNF receptors or TH1 cells. Adipocity is characterized by 
the infiltration of macrophages and subsequent low-grade inflammation in AT (Weisberg 
et al. 2003; Xu et al. 2003). The macrophage population in obesity is a heterogeneous 
combination of the pro-inflammatory M1 phenotype, which produces ROS and pro-
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inflammatory cytokines, and the anti-inflammatory M2 phenotype associated with tissue 
repair and the resolution of inflammation (Chinetti-Gbaguidi and Staels 2011). Elevated 
levels of TNF-α have been shown to induce an insulin resistant state (Hotamisligil et al. 
1993). The secretion of most adipokines is increased in obesity. However, the levels of 
protective adiponectin exhibit an inverse correlation with the AT area (Ryo et al. 2004). In 
addition to TNF-α and IL-6, the adipokines with pro-inflammatory properties include leptin, 
resistin, retinol-binding protein 4, lipocalin 2, IL-18, angiopoietin-like protein 2, CC-
chemokine ligand 2, CXC-chemokine ligand 5, and nicotinamide phosphoribosyltransferase. 
(Ouchi et al. 2011; Hassan et al. 2012)  
 There are multiple differences between AT depots (Lee et al. 2012). Visceral AT 
associates with greater insulin resistance than subcutaneous AT (Lemieux et al. 1996; 
Wajchenberg et al. 2002). In general, the production of pro-inflammatory cytokines, 
angiotensin, and PAI-1 is greater in the visceral than the subcutaneous AT depot 
(Wajchenberg et al. 2002; Lee et al. 2012). The opposite effect is observed with the levels 
of leptin and adiponectin (Wajchenberg et al. 2002). HSL activity and the maximum 
lipolytic capacity are correlated with adipocyte size and their capacity to expand, and 
subcutaneous adipocytes are generally larger than omental ones (Reynisdottir et al. 1997). 
In obesity, perivisceral AT contains more saturated fatty acids (SFAs) and 
monounsaturated fatty acids (MUFAs) than subcutaneous AT (Garaulet et al. 2001).  
 
1.2.2. Liver lipid metabolism and non-alcoholic fatty liver disease 
 
The liver is a major organ in lipid, glucose, and protein metabolism. Hepatocytes 
constitute approximately 80% of the cell population; the others include Kupffer cells, 
endothelial cells, stellate cells, and various immune and vascular cells. The liver acquires 
lipids via lipoprotein internalization, endogenous de novo lipogenesis, and the uptake of 
circulating FFAs. The aspects of lipoprotein metabolism are discussed in the section 1.1.1. 
The fate of FFAs is defined by the metabolic state. In the fed state, FFAs are processed into 
TGs and stored in lipid droplets or assembled into VLDLs, whereas in the fasting state they 
are utilized for energy production via mitochondrial β-oxidation. (Bechmann et al. 2012)  
 The transformation of carbohydrates into fatty acids, de novo lipogenesis, takes 
place in the cytoplasm. The rate-limiting enzyme is acetyl-CoA carboxylase (ACC), which 
converts the principal building block, acetyl-CoA, into malonyl-CoA. The following 
synthesis is catalyzed by fatty acid synthase yielding palmitic acid. Palmitic acid may be 
elongated into stearic acid by elongase and both of these SFAs are desaturated by 
stearoyl-coenzyme A desaturases. Circulating FFAs are mainly taken up by the liver in a 
regulated manner via various transport proteins. The major hepatic FATPs are FATP2 and 
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FATP5, while others include liver FABP, glutamate–oxaloacetate-transaminase 2, FT/CD36, 
and caveolin 1 (Zhou et al. 1995; Trigatti et al. 1999; Huang et al. 2002; Smathers and 
Petersen 2011; Kazantzis and Stahl 2012). FFAs are toxic to hepatocytes and are therefore 
rapidly catalyzed into TGs by mitochondrial glycerol-3-phosphate-acyltransferase and 
DGAT. These processes are regulated by glucose and insulin levels via sterol SREBP-1c and 
chREBP and, furthermore, via the nuclear receptors peroxisome proliferator-activated 
receptors (PPARs), LXR, and farnesoid X receptor (FXR). (Dentin et al. 2005; Bechmann et 
al. 2012) 
 The hydrolysis of lipoproteins and hepatic lipogenesis-derived TGs is processed in 
lysosomes. The lipid droplets may also be degraded by macroautophagy, in which 
autophagosomes composed of lipid droplets and cellular components are fused together 
with lysosomes followed by the release of FFAs (Singh et al. 2009). The released, de novo 
generated, and internalized FFAs may be oxidized in mitochondria, peroxisomes, and the 
endoplasmic reticulum (ER). The membrane-crossing process requires the activation of 
FAs by fatty acyl-CoA synthase. Short-, medium-, and long-chained FAs are predominantly 
oxidized in mitochondria, whereas very-long-chain FAs are oxidized within peroxisomes. 
(Reddy 2001)   
 Non-alcoholic fatty liver disease (NAFLD) is the most prevalent liver disorder in 
Western societies and affects 20–40% of the general adult population (Ratziu et al. 2010). 
It is a cluster of hepatic disturbances ranging from the accumulation of TGs, defined as 
steatosis, to non-alcoholic steatohepatitis (NASH) with or without fibrosis (de Alwis and 
Day 2008; Bechmann et al. 2012; Kawano and Cohen 2013). The prevalence is steadily 
increasing along with the obesity and metabolic syndrome, and NAFLD is actually 
considered to be a liver manifestation of metabolic syndrome. Depending on the 
definition and/or diagnosis methods, 30–80% of obese people suffer from NAFLD and 
approximately 20% from NASH (Wanless and Lentz 1990; Brea and Puzo 2012). Mild 
steatosis (less than 30% of hepatocytes affected) is a relatively benign condition whereas 
NASH is characterized by hepatocyte injury, inflammation, and apoptosis, and may 
progress into a fibrotic state with an increased risk of cirrhosis and hepatocellular 
carcinoma (Starley et al. 2010).  
 The pathogenic process in NAFLD and NASH is a complex interplay between lipid 
and glucose metabolism, insulin resistance, and inflammation (Bechmann et al. 2012; 
Kawano and Cohen 2013). It is initiated by elevated circulating FFA levels, which 
predominantly result from insulin resistance-induced dysregulation of AT lipolysis. 
Amplified hepatic FFA uptake and TG synthesis lead to an increase in the intracellular FFA 
pool and lipid droplets. Hyperinsulemia and hyperglycemia induce the up-regulation of 
SREBP-1c and chREBP, which enhances hepatic de novo lipogenesis and inhibits the β-
oxidation pathway by excess malonyl-CoA. (Kawano and Cohen 2013) In addition, 
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prolonged elevation in cellular lipid levels inhibits macroautophagy, which promotes lipid 
accumulation (Singh et al. 2009). The adverse development from NAFLD to NASH is related 
to increased inflammation, apoptosis, mitochondrial dysfunction, and ER stress. Abundant 
FFAs and their metabolites cause lipotoxicity, and elevated levels of SFAs have been 
shown to induce hepatocytes apoptosis (Li et al. 2009). Impaired mitochondrial function 
enhances ω-oxidation in ER and increases ROS production and lipid peroxidation. In 
addition, serum TNF-α-mediated inflammation is elevated among patients with NASH. 
(Krawczyk et al. 2010; Smith and Adams 2011; Bechmann et al. 2012) 
 NAFLD is highly prevalent among obese and diabetic patients and consequently 
associates with many ASVD risk factors. Nevertheless, NAFLD is independently associated 
with increased carotid intima-media thickness, the number of atherosclerotic lesions, and 
endothelial dysfunction (Brea et al. 2005; Targher et al. 2006; Thakur et al. 2012). The 
association with increased carotid intima-media thickness has also been confirmed by a 
meta-analysis including seven case-control studies (Sookoian and Pirola 2008). Prevalent 
NASH predicts cardiovascular biomarkers including elevated serum CRP, fibrinogen, PAI-1, 
and decreased adiponectin levels (Targher et al. 2008). NAFLD is associated with an 
increased risk of CAD and prevalent CHD (Arslan et al. 2007; Feitosa et al. 2013). The 
overall risk of coronary events is high among patients with NAFDL, and especially with 
NASH (Sung et al. 2009). In addition, NALDF patients develop metabolic disorders such as 
diabetes, hypertension, and dyslipidemia more often than healthy controls (Fan et al. 
2007). Altogether, patients with NAFLD have a higher incidence of cardiovascular 
morbidity and mortality than controls (Brea and Puzo 2012).  
 
1.3. Infections and atherosclerosis 
 
The evidence of pathogen contribution in the progression of atherosclerosis has been 
accumulating in recent decades. In 1978 Fabricant et al. reported that chicken with 
Marek’s disease herpesvirus infection developed advanced atherosclerotic lesions on a 
cholesterol-rich diet (Fabricant et al. 1978). C. pneumoniae was detected from fatty 
streaks in 1992 by Shor et al. Since then, a body of evidence has been acquired from 
seroepidemiological studies and the development of molecular techniques has facilitated 
the detection of numerous pathogens from atherosclerotic plaques. Studies utilizing 
animal models have further supported the role of pathogens in atherogenesis. (Rosenfeld 
and Campbell 2011) 
 The infectious agents may accelerate the atherogenesis by direct and indirect 
mechanisms. Direct mechanisms include infection of the vascular wall cells, which may be 
verified by detecting and isolating microbes exclusively from the lesion sites. In addition to 
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C. pneumoniae, many infectious agents have been detected from plaques, including 
periodontal bacteria, H. pylori, cytomegalovirus, hepatitis C virus, and human 
immunodeficiency virus, Epstein Barr virus, herpes simplex viruses, Enterobacter 
hormaechei, and enteroviruses (Haraszthy et al. 2000; Kwon et al. 2004; Ibrahim et al. 
2005; Kaplan et al. 2006; Reszka et al. 2008; Eugenin et al. 2008; Boddi et al. 2010; 
Rafferty et al. 2011). Viability has been demonstrated for C. pneumoniae and E. 
hormaechei (Nyström-Rosander et al. 2006; Ramirez 1996; Rafferty et al. 2011). One 
indirect approach is mediated by serum biomarkers: local infection in lungs and 
periodontium, for example, may generate an increased amount of circulating pro-
inflammatory cytokines and inflammation markers, which enhance the systemic 
inflammation and, moreover, the atherogenesis. Increased serum cytokine and acute 
phase proteins have been associated with periodontal disease, C. pneumoniae, H. pylori, 
cytomegalovirus, hepatitis A virus, Epstein Barr virus, and influenzavirus infections 
(Rosenfeld and Campbell 2011). Another indirect mechanism is molecular mimicry 
between bacterial and self-antigens, which generates cross-reactive auto-antibodies. This 
phenomenon particularly affects heat shock protein (hsp) 60 and has been demonstrated 
with C. pneumoniae, P. gingivalis, A. actinomycetemcomitans, and H. pylori (Mayr et al. 
1999; Ford et al. 2007; Okada et al. 2007; Alfakry et al. 2011). Animal models have 
provided supporting evidence for the association of C. pneumoniae (Fong et al. 1999), P. 
gingivalis (Li et al. 2002), A. actinomycetemcomitans (Zhang et al. 2010), H. pylori (Ayada 
et al. 2009), cytomegalovirus (Vliegen et al. 2002), and influenzavirus (Naghavi et al. 2003) 
infection with accelerated atherogenesis.  
 It is hypothesized that the observed infectious agent-derived amplifying effects 
on atherogenesis in humans result from a combination of direct and indirect actions of 
multiple microbes, termed the pathogen burden. This hypothesis is supported by several 
studies (Zhu et al. 2000; Georges et al. 2003; Desvarieux et al. 2005; Renvert et al. 2006; 
Mundkur et al. 2012). However, single infectious agents, such as A. 
actinomycetemcomitans, have been associated with ASVDs independently of the 
pathogen burden (Spahr et al. 2006).  
 
1.3.1. Lipopolysaccharide and inflammation response 
 
The Gram-negative bacterial cell wall is a bilayer and comprises an inner membrane, a 
peptidoglycan layer, and an outer membrane. Amphipathic LPS (endotoxin) is a major 
component of the outer membrane and consists of three structural and functional 
subregions: hydrophobic lipid A anchors to the membrane and the hydrophilic sugar 
moiety, the core oligosaccharide and O-specific side chain (O-antigen), projects towards 
the extracellular matrix. The shape of lipid A determines the toxic moiety of LPS and the 
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general structure is highly conserved among pathogenic Gram-negative bacteria. 
(Rietschel et al. 1994) LPS is a very potent activator of host inflammatory responses and 
may accelerate atherosclerosis by promoting and sustaining the inflammatory status. In 
humans, acute low-level endotoxemia has been shown to induce elevated serum levels of 
TNF-α, TNF receptors, IL-6, cortisol, TGs, and FFAs within a few hours after infection. 
Serum amyloid A and CRP levels peak in the later phase at 24 h post-infection, and LDLs, 
phospholipid, and cholesterol levels gradually decrease. (Hudgins et al. 2003) LPS 
stimulates various cell types including leukocytes, vascular wall cells, and adipocytes. 
However, the monocyte/macrophage responses are of particular importance. LPS 
signaling is a complicated action involving a complex of LPS, LPS binding protein (LBP), and 
membrane-bound or soluble CD14, which binds to plasma membrane TLR4 on host cells. 
(Wright et al. 1990; Maeshima and Fernandez 2013) TLR4 signaling is mediated by MyD88 
and is mainly used to produce pro-inflammatory cytokines, INF-γ, and chemokines via 
mitogen-activated protein kinase and NF-κB. Induction of the MyD88-independent 
pathway yields type I INFs. (Brown et al. 2011) Activation of macrophages by LPS also 
induces the production of ROS (Victor et al. 2004). Endothelial cells and SMCs respond to 
the stimulus by expressing inducible adhesion molecules, chemokines, and cytokines, 
which augment the atherogenesis (Loppnow et al. 2008). LPS may be released from the 
bacterial cell membrane by PLTP, and the neutralization and clearance from the 
circulation is facilitated by attaching to CD14 and lipoprotein-carried LBP (Wurfel et al. 
1994; Vesy et al. 2000). LPS binds to all lipoproteins; however, the HDLs are particularly 
important in neutralizing LPS (Ulevitch et al. 1979; Levels et al. 2001; Murch et al. 2007). 
Chronic infections may decrease the proatherogenic potential of HDL, and the infection-
derived increase in binding to other lipoproteins may enhance the proatherogenicity of 
LPS (Pussinen et al. 2004; Kallio et al. 2008; Kallio et al. 2012). After binding to the 
lipoproteins, LPS may be delivered to the liver and secreted in bile.   
 
1.4. Infectious agent Chlamydia pneumonia 
 
C. pneumoniae is a Gram-negative bacterium and belongs to the phylum and class 
Chlamydiae. Diverse members of this class are obligatory intracellular pathogens of 
eukaryotic cells and able to infect a wide range of hosts, from amoebae to humans. The 
taxonomy of the order Chlamydiales continues to be refined and the genus Chlamydia 
currently includes nine species (Stephens et al. 2009; Greub 2010; Schoborg 2011). The 
major human pathogens are C. pneumoniae, C. trachomatis, and C. psittaci. C. 
pneumoniae was originally discovered as a C. psittaci TWAR strain and was reclassified to 
C. pneumoniae in 1989 (Grayston et al. 1989).  
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  C. pneumoniae is a common pathogen accounting for generally mild upper and 
lower respiratory tract infections. Approximately 7% of community acquired pneumoniae 
(CAP) are caused by C. pneumoniae (Arnold et al. 2007). Clinical presentations of the 
disease are diverse: from asymptomatic to a life-threatening state. The seropositivity for C. 
pneumoniae is high, being up to 80% among the elderly. Thus, almost everyone is infected 
at least once in their lifetime and re-infections are frequent (Grayston et al. 1990). In 
addition to CAP, C. pneumoniae is associated with bronchitis, asthma, chronic obstructive 
pulmonary disease, lung cancer, arthritis, multiple sclerosis, age-related macular 
degeneration, chronic fatigue syndrome, chronic skin wounds, Alzheimer's disease, 
diabetes, and cardiovascular diseases. (Hogan et al. 2004; Burillo and Bouza 2010) 
 The infection of chlamydiae involves both chlamydial proteins and Chlamydia-
derived exploitation of the host system. C. pneumoniae primarily infects mucosal 
epithelial cells. The complex development cycle includes two morphologically and 
functionally distinct bacterial cell forms. The small, infectious and metabolically inert 
elementary bodies (EBs) are specialized in extracellular survival and dissemination. The 
biphasic cycle begins with the adherence of EBs on the host cell surface. The 
internalization of EBs occurs via endocytosis in host-derived vacuoles, termed inclusions. 
The EBs differentiate in these intracytoplasmic inclusions into larger, metabolically active, 
non-infectious reticulate bodies (RBs). Transcriptionally active RBs multiply by binary 
fission, forming more inclusions, and chlamydial antigens are released to the host cell 
surface. In the late state, from 48 to 72 h post-infection, the RBs condense and re-
differentiate into EBs, which are finally released via a lytic or extrusion pathway and are 
able to initiate the next infection cycle. (Hogan et al. 2004; Hybiske and Stephens 2007; 
Burillo and Bouza 2010) The complete infection cycle of C. pneumoniae in vitro has been 
shown to take approximately 84 h (Wolf et al. 2000).   
 Upon physiological stress and external stimuli chlamydiae may enter in a 
persistent state, where metabolism and binary fission of RBs are suppressed and re-
differentiation into EBs is abated. Instead, RBs convert into larger, less electron-dense, 
pleomorphic RBs termed aberrant bodies (ABs). Persistent chlamydiae are viable but non-
infectious and non-cultivable, and the suspended state of infection maintains a long-term 
existence within the host cell. (Schoborg 2011) C. pneumoniae persistence has been 
studied extensively in vitro and it can be induced in cell culture by antibiotics (Wolf et al. 
2000), INF-γ (Mehta et al. 1998; Pantoja et al. 2001; Timms et al. 2009), iron deprivation 
(Timms et al. 2009), and tobacco smoke (Wiedeman et al. 2004; Wiedeman et al. 2005). 
Monocytes and continuous cultures may spontaneously become persistently infected by C. 
pneumoniae (Airenne et al. 1999; Kutlin et al. 2001) and, a bacteriophage infection may 
enhance the strain’s potential to become persistent (Karunakaran et al. 2002). Although 
experimental in vivo persistence models are not yet available, the prevalent clinical and 
experimental data from human and animal investigations provide evidence for in vivo 
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persistence and reactivation of C. pneumoniae. The ABs of C. pneumoniae have been 
detected from macrophages in human aortic valve samples (Skowasch et al. 2003), 
atherosclerotic tissue (Borel et al. 2008), and coronary atheromas (Borel et al. 2012), and 
the lung infection has been successfully reactivated in mouse studies (Malinverni et al. 
1995; Laitinen et al. 1996). In addition, Bunk et al. suggest that a persistent C. pneumoniae 
infection associated antibody-response pattern may be detected from serum samples and 
utilized in discriminating patients with past or persistent infections (Bunk et al. 2008).  
 
1.4.1. C. pneumoniae and ASVD  
 
Even though C. pneumoniae has a significant role as an acute respiratory track pathogen, 
the majority of C. pneumoniae studies have focused on the potential association with 
other chronic diseases, particularly ASVDs. In 1988 Saikku et al. proposed that patients 
with acute myocardial infarction (MI) and chronic CHD have an elevated antibody 
response and higher seropositivity frequency for C. pneumoniae than controls (Saikku et al. 
1988). Numerous histopathological, experimental animal model, and seroepidemiological 
cross-sectional and prospective studies have been performed since those days (Watson 
and Alp 2008). 
 The first histological evidence for the association was reported by Shor et al. in 
1992, when they found C. pneumoniae EBs in coronary artery fatty streaks by transmission 
electron microscopy and immunocytochemistry (Shor et al. 1992). Meta-analysis including 
43 studies concluded that 46% of atheromatous arteries were positive for C. pneumoniae 
compared to less than 1% of healthy arteries (Kalayoglu et al. 2002). The bacteria have 
been detected by electron microscopy, immunocytochemistry, PCR, immunofluorescence, 
and in situ hybridization (Watson and Alp 2008). In addition, studies have managed to 
prove the viability of the bacteria by culturing methods (Ramirez 1996; Jackson et al. 1997) 
and mRNA detection (Johnston et al. 2001; Johnston et al. 2005; Nyström-Rosander et al. 
2006). 
 Animal studies conducted on rabbits, mice, rats, and pigs have provided 
increasing evidence for an association and even for causality. New Zealand White rabbits 
on a regular diet have been shown to develop atherosclerotic lesions (Fong et al. 1997; 
Fong et al. 1999) and an increase in intima media thickness (Coombes et al. 2002) when 
inoculated from 1 to 3 times with C. pneumoniae. Normocholesterolemic C57BL/6J mice 
and LDLr-deficient mice with moderate lipid levels need an atherogenic diet with repeated 
C. pneumoniae inoculations in order to induce accelerated atherosclerosis (Hu et al. 1999; 
Blessing et al. 2001; Törmäkangas et al. 2005). In a hypercholesterolemic apoE-deficient 
strain, the proatherogenic effects of C. pneumoniae infection were detectable on a regular 
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chow diet (Moazed et al. 1999; Liuba et al. 2000), and in apoE-Leiden mice the response 
has been shown with an atherogenic diet (Ezzahiri et al. 2002). Hyperlipidemic 
hypertension rats on a regular chow diet exhibited enhanced progression of CAD and 
decreased survival after C. pneumoniae infection (Herrera et al. 2003). In pigs, the 
infection has been demonstrated to associate with endothelial dysfunction (Liuba et al. 
2003; Liuba et al. 2006) and moderate intimal proliferation (Pislaru et al. 2003). 
 Despite the promising histopathological and animal study results, conclusions 
from seroepidemiological studies and antibiotic treatment trials are less evident. 
Individual cross-sectional studies have significantly associated elevated C. pneumoniae 
antibody titres with increased ORs for MI, CAD, stroke, angina pectoris, transient 
ischaemic attack, and stenosis (Watson and Alp 2008). A meta-analysis by Bloemenkamp 
et al., including 29 seroepidemiological studies from 1997 to 2000, demonstrated an 
overall weighted OR of 2.0 (95% CI 1.5–2.6) for clinically manifesting atherosclerosis 
(Bloemenkamp et al. 2003). The OR for acute events was higher than for chronic events 
(Watson and Alp 2008). In addition, multiple prospective studies have significantly 
associated C. pneumoniae antibodies with increased ORs for early atherosclerosis, MI, and 
death. However, the three existing meta-analyses were only able to show a weak 
connection (Danesh et al. 2000; Danesh et al. 2002) or no significant connection at all 
(Bloemenkamp et al. 2003) between increased C. pneumoniae antibody titres and the 
cardiovascular outcome. There have also been numerous studies investigating the 
association with the presence of C. pneumoniae DNA in peripheral blood mononuclear 
cells (PBMC) and CVD. A systematic review including 18 case-control studies reported that 
the prevalence of C. pneumoniae DNA in PBMC is 14.3% in CVD patients and 8.5% in 
controls with an unadjusted OR of 2.0 (95% CI 1.3–3.1) for CVD (Smieja et al. 2002). If C. 
pneumoniae contributes to the prevalence of adverse ASVD outcomes, the patients might 
benefit from C. pneumoniae-targeted antibiotics. Nevertheless, the combined results from 
clinical intervention trials with macrolides do not support this hypothesis (Wells et al. 
2004; Andraws et al. 2005; Deniset and Pierce 2010). (Watson and Alp 2008)  
 C. pneumoniae is assumed to participate in all stages of progression of 
atherosclerosis. The dissemination from the lungs to the vascular wall may be achieved via 
infected circulating alveolar-derived monocytes (Gieffers et al. 2004). Once at the vascular 
wall, the bacteria may infect endothelial cells, macrophages, and SMCs, and thereby 
stimulate the production of pro-inflammatory cytokines, ROS, and adhesion molecules 
(Godzik et al. 1995; Azenabor et al. 2005; Högdahl et al. 2008). Chlamydial GroEL possess 
atherogenic potential and induce the expression of lectin-like oxidized LDL receptor 1 in 
endothelial cells (Lin et al. 2011). The antibodies against GroEL express cross-reactivity 
with human hsp60 and mediate endothelial cytotoxicity (Mayr et al. 1999). The C. 
pneumoniae infection of macrophages and chlamydial LPS per se induce foam cell 
formation and the oxidation of LDL (Kalayoglu and Byrne 1998; Kalayoglu et al. 1999; 
Dittrich et al. 2004). This, in turn, boosts the proliferation of SMCs (Chahine et al. 2011) 
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and promotes plaque formation. The deleterious effects on plaque stability and thrombus 
formation may be augmented by increased expression of MMPs and pro-coagulant factor 
PAI-1 by infected vascular cells (Dechend et al. 1999; Rödel et al. 2003). 
 
1.5. Periodontal disease 
 
Periodontal disease is a chronic multibacterial infection destroying tooth-supporting tissue 
structures: the gingiva, cementum, periodontal ligament, and alveolar bone. The initiation 
of the disease arises from disturbances in the dental biofilm and host homeostasis. The 
human oral microbiome is estimated to consist of several thousand species and the 
dental-plaque biofilm is a complex polymicrobial ecosystem (Dewhirst et al. 2010; Huse et 
al. 2012). It is in continuous flux and the bacteria interact cooperatively and competitively 
with each other (Hojo et al. 2009). In a healthy state, there is a subtle balance between 
environmental, biofilm, and host tissue factors, and the biofilm remains relatively stable 
(Kumar et al. 2006). However, the cross-talk between host tissue and the biofilm may be 
altered by changes in bacterial composition and quantity. Periodontal disease is 
associated with high supra- and subgingival plaque bacterial numbers, increase in 
subgingival plaque re-development, and a microbial shift towards putative pathogens 
(Marsh 1994; Haffajee et al. 1998; Ximénez-Fyvie et al. 2000; Uzel et al. 2011). The 
progression of periodontal disease begins from plaque at the gingival margin and 
proceeds towards the alveolar bone by destroying the connective tissue (Figure 3). The 
symptoms include swollen and bleeding gingival papilla, increased depth of the gingival 
sulcus, deepening of periodontal pockets, and alveolar bone loss. If left untreated, the 
disease leads to the loss of teeth. The tissue destruction is mainly due to the host defense 
response against microbial challenge. The bacteria produce toxins and proteases, and 
impair the host innate immune response, thereby creating a deleterious cascade. The 
inflamed gingival epithelium proliferates, expresses various pro-inflammatory cytokines, 
adhesion molecules, defensins, IL-8, TLRs, CD14, and LBP, and facilitates the transition of 
activated neutrophils to the site. The enhanced production of hydrolytic enzymes and 
altered alveolar bone remodeling by induction of receptor activator of NF-κB ligand 
(RANKL) generates the eventual tissue loss and irreversible bone resorption. (Darveau 
2010) 
 Periodontitis is a prevalent disease worldwide and particularly affects the middle-
aged and elderly. The disease may be localized around one to few teeth or be generalized 
in the whole periodontium. Among the general adult population, the most common 
disease type is chronic disease. A rapidly progressive form, aggressive periodontitis, 
primarily affects younger patients (Lang et al. 1999). The frequency of mild or moderate 
chronic disease ranges from 13% to 57% worldwide (Rylev and Kilian 2008). In Finland, 64% 
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of the adult population has deepened periodontal pockets and 21% suffer from more 
severe forms of the disease (Knuuttila and Suominen-Taipale 2008). The prevalence of 
aggressive periodontitis varies greatly in relation to ethnicity from <1% in Caucasian 
populations to 7.6% in Maroccan and 34% in Israeli adolescents (Stabholz et al. 1998; 
Haubek et al. 2001; Rylev and Kilian 2008).    
  
     
                 
Figure 3. Periodontal anatomy in health and disease. The left side of molar tooth represents the 
healthy peridontium and the right side the consequences of periodontal disease. (Lockhart et al. 
2012) Reprinted with permission from Wolters Kluwer Health. 
     
1.5.1. Periodontal pathogens 
 
The number of documented bacteria associated with periodontal disease has increased 
considerably within last 10 years, which is largely due to advances in microbial detection, 
quantification, and identification methodology. Culturing methods have a long tradition in 
the characterization of oral bacteria. Extensive culturing studies were conducted in the 
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early 1980s by Moore et al. They isolated and identified 190 taxa from patients with 
severe periodontitis and 171 taxa from patients with chronic periodontitis. The 
predominant species in both cases included Fusobacterium nucleatum, Eubacterium 
nodatum, Mogibacterium timidum, Parvimonas micra, and Prevotella intermedia. (Moore 
et al. 1982; Moore et al. 1983) The prevalence of A. actinomycetemcomitans has been 
proven to be very high (75–100%) among adolescents with aggressive periodontitis (Slots 
et al. 1980; Slots and Ting 1999). The landmark study in the culture-independent field was 
conducted by Socransky et al. in 1998, when they analyzed the presence and levels of 40 
taxa in >13,000 subgingival plaque samples from subjects with or without periodontitis. 
Whole-genome DNA probes (“checkerboard” hybridization) identified five microbial 
complexes. The “red-complex” bacteria, namely P. gingivalis, Treponema denticola, and 
Tannerella forsythia, had a strong association with disease-related variables, such as 
periodontal pocket depth and bleeding on probing. The second, “orange”, complex related 
to pocket depth consisted of Campylobacter gracilis, Campylobacter rectus, 
Campylobacter showae, E. nodatum, Fusobacterium subspecies, P. intermedia, P. micra, 
Prevotella nigrescens, and Streptococcus constellatus. (Socransky et al. 1998) Other 
checkerboard studies have also associated these bacteria with periodontal disease 
(Ximénez-Fyvie et al. 2000; Ximénez-Fyvie et al. 2000).  Nevertheless, all of these 
conventional putative periodontal pathogens have also been detected among 
periodontally healthy subjects (Ximénez-Fyvie et al. 2000; Kuboniwa et al. 2004; Könönen 
et al. 2007). A new checkerboard panel introduced by Dahlen et al. in 2006 found, in 
addition to conventional pathogens, a significantly elevated prevalence of Filifactor alocis, 
Prevotella tannerae, and Porphyromonas endodontalis in diseased sites (Dahlen and 
Leonhardt 2006). 
 In the 21st century, 16S rRNA cloning and sequencing-based studies emerged, 
providing more information on the substantial microbial diversity in oral sites. In 2001, 
Paster et al. identified 29 species or phylotypes in subgingival plaque as putative 
pathogens for periodontitis by 16S rRNA analysis (Paster et al. 2001) (Table 1). Ten of the 
associated phylotypes were not yet cultivable. The results from Paster et al. were largely 
repeated in 16S rRNA-based analysis by Hutter et al. in 2003. In PCR analysis using the 
same probe set than Paster et al. (2001), the 15 bacteria associated with chronic 
periodontitis also included Anaeroglobus geminatus F. alocis, P. gingivalis, P. micra, T. 
denticola, and T. forsythia also (Kumar et al. 2003).  In 2005, Kumar et al. identified new 
associations, e.g. for Peptostreptococcus and Selenomonas (Kumar et al. 2005). The 
bacterial results of these four studies are compared in Table 1. Only A. geminatus, F. alocis, 
and T. forsythia were associated with the disease in all four studies. The 16S rRNA-based 
study by Faveri et al. in 2008 analyzed 1007 clones from patients with generalized 
aggressive periodontitis and found that species of Selenomonas dominated the diseased 
sites and S. sputigena was the most commonly detected bacterium. The Human Oral 
Microbe Identification Microarray (HOMIM) study by Colombo et al. in 2009 showed that 
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patients with refractory periodontitis were distinguishable from those with treatable 
periodontitis or the periodontally healthy by a significantly higher prevalence of putative 
periodontal pathogens (Colombo et al. 2009).  
 
Table 1. Periodontal disease-associated bacteria as determined with culture-independent 
methods 
Species or phylotypes associated with 
periodontal disease 
Paster et 
al. 2001 
Kumar et 
al. 2003 
Hutter et 
al. 2003 
Kumar et 
al. 2005 
16S rRNA 
cloning 
PCR 
16S rRNA 
cloning 
16S rRNA 
cloning 
Abiotrophia adiacens x    
Anaeroglobus geminatus (Megasphaera 
BB166) 
x x x x 
Atopobium parvulum x  x  
Atopobium rimae x  x  
Atopobium sp. oral clone C019    x 
Bacteroidetes clone AU126  x   
Campylobacter gracilis x    
Campylobacter rectus x  x  
Campylobacter sp. oral clone BB120    x 
Campylobacter sputorum sputorum    x 
Catonella sp. oral clone BR063    x 
Catonella morbi x  x  
Cryptobacterium curtum  x   
Deferribacteres sp. oral clone BH007    x 
Deferribacteres clone D084/BH017 x x   
Deferribacteres W028 x    
Deferribacteres W090 x   x 
Desulfobulbus sp. oral clone CH031    x 
Desulfobulbus sp. clone R004 x  x x 
Dialister sp. oral clone MCE7_134    x 
Dialister strain GBA27  x   
Dialister pneumonsintes x  x x 
Eubacterium sp. oral strain A35MT    x 
Eubacterium sp. clone PUS9.170 x  x  
Eubacterium saphenum x x x  
Filifactor alocis x x x x 
Fusobacterium animalis x    
Gemella haemolysans x  x  
Granulicatella adiacens   x  
Haemophilus paraphrophilus   x  
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Haemophilus parainfluenzae x    
Megasphaera sp. oral clone BS073    x 
Megasphaera sp. oral clone MCE3_141    x 
OP11 clone X112  x   
Parvimonas micra  x  x 
Peptostreptococcus anaerobius    x 
Peptostreptococcus sp. oral clone CK035    x 
Porphyromonas endodontalis x x x  
Porphyromonas gingivalis x x x  
Prevotella denticola  x   
Prevotella tannerae x    
Selenomonas flueggei-like sp. clone AH132    x 
Selenomonas sp. oral clone D0042    x 
Selenomonas sp. oral clone EY047    x 
Selenomonas sp. strain GAA14 x  x  
Streptococcus constellatus x  x  
Streptococcus sp. oral strain 9F    x 
Streptococcus sp. oral clone DP009    x 
Tannerella forsythia x x x x 
Treponema lecithinolyticum  x   
TM7 clone I025 x    
Treponema sp. clone 1:G:T21 x    
Treponema sp. clone 2:10:D12 x    
Treponema sp. strain 6:H:D15A-4    x 
Treponema denticola  x   
Treponema socranskii sub sp. buccale x  x  
Uncultured bacterium D084   x  
 
 The consistent finding from the extensive 16S rRNA-based cloning and 
sequencing studies is that the predominant species in periodontitis-affected sites may be 
Gram-positive rather than Gram-negative. This result is in concordance with observations 
from a precise anaerobe cultivation study in which 60% of 422 isolates in periodontal 
pockets proved to be Gram-positive bacteria (Uematsu and Hoshino 1992). However, the 
results from a recent deep-sequencing study support the conventional “microbial shift” 
hypothesis and demonstrate that the dominating community in periodontal disease is 
Gram-negative (Liu et al. 2012). 
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1.5.2. Characteristics of Aggregatibacter actinomycetemcomitans 
 
The most convincing evidence for a specific bacterium in periodontal disease pathogenesis 
is for A. actinomycetemcomitans. Several individual studies have demonstrated a high 
prevalence of the bacterium and elevated serum A. actinomycetemcomitans antibody 
levels among young patients diagnosed with aggressive periodontitis (Christersson 1993; 
Lopez et al. 1995; Celenligil and Ebersole 1998; Haubek et al. 2001; Cortelli et al. 2005). 
Additionally, three prospective cohort studies have strongly associated A. 
actinomycetemcomitans with localized aggressive juvenile periodontitis among Maroccan, 
Indonesian, African-American, and Hispanic adolescents (Van der Velden et al. 2006; Fine 
et al. 2007; Haubek et al. 2008).   
 A. actinomycetemcomitans is a Gram-negative facultative anaerobe and a 
member of the indigenous oral microbiota. Additionally, it is recognized as an 
opportunistic pathogen that may occasionally induce non-oral invasive infections such as 
endocarditis and abscesses (Paju et al. 2000; Paturel et al. 2004). A. 
actinomycetemcomitans is able to initially colonize the oral cavity at very early age 
(Cortelli et al. 2008). The prevalence of A. actinomycetemcomitans varies greatly between 
ethnic groups, from 3% in Spain to 78% in Vietnam, and the pathogen has also been 
detected from periodontally healthy individuals (Slots and Ting 1999; Sanz et al. 2000; 
Rylev and Kilian 2008). In Finnish adult population the saliva carriage rate of A. 
actinomycetemcomitans has reported to be 20.0% (Könönen et al. 2007). The strains are 
classified into six serotypes (a–f) according to properties of the O-antigen of LPS (Kaplan et 
al. 2001), and the serotype pattern varies greatly among different populations and 
according to the periodontal status (Rylev and Kilian 2008). Nevertheless, serotypes a, b, 
and c have been reported as the most frequent in several studies (Saarela et al. 1992; 
Chen et al. 2010; Cortelli et al. 2011).  
 The virulence potential of A. actinomycetemcomitans differs greatly between 
clones and strains. The major virulence factors of A. actinomycetemcomitans include LPS, 
fimbriae, leukotoxin (ltxA), and cytolethal distending toxin (CDT). (Henderson et al. 2010). 
Most of the strains are able to use hemoglobin as an iron source (Hayashida et al. 2002). 
Environmental stress, i.e. iron and nutrient depletion and anaerobic conditions, has been 
reported to enhance the expression of fimbriae, LPS, and other biofilm formation 
determinants (Amarasinghe et al. 2009). A. actinomycetemcomitans LPS has been shown 
to induce MMPs expression in gingival fibroblasts, and activate MMP-2 and up-regulate 
the expression of RANKL in human periodontal ligament cells (Tiranathanagul et al. 2004; 
Bodet et al. 2007). CDT and ltxA express strain- and clone-dependent variation (Brogan et 
al. 1994; Kolodrubetz et al. 1996; Fabris et al. 2002; Nishikubo et al. 2006). Leukotoxin may 
be located on the cell surface or secreted in large amounts from bacteria (Kachlany et al. 
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2000). Single nucleotide polymorphism affects the toxicity of CDT and may explain the 
significant heterogeneity of cytotoxic activity of A. actinomycetemcomitans (Nishikubo et 
al. 2006). In addition to general immunosuppressive function, the CDT of A. 
actinomycetemcomitans has been reported to induce RANKL expression in gingival 
fibroblasts, periodontal ligaments, and T cells (Belibasakis et al. 2005; Belibasakis et al. 
2008). Some A. actinomycetemcomitans strains are able to invade the host epithelial cells 
and the mechanism varies between the strains from actin-dependent to actin-
independent (Meyer et al. 1991; Brissette and Fives-Taylor 1999). It has also been 
suggested that A. actinomycetemcomitans benefits from the presence of H2O2-generating 
streptococci and may evade the host innate immune system by producing complement 
resistance protein apiA induced by H2O2 (Ramsey and Whiteley 2009). A particularly 
pathogenic JP2 clone is strongly associated with aggressive periodontitis among 
adolescents of African descent (Haubek et al. 1997; Haubek et al. 2001). It carries a unique 
deletion in the promoter region of the leukotoxin gene operon, which amplifies the 
expression of leukotoxin (Brogan et al. 1994). Due to the presence of hgpA pseudogene, 
the JP2 clone is unable to utilize hemoglobin as an iron source (Hayashida et al. 2002).  
 
1.5.3. Detection of periodontal pathogens 
 
Studies have employed various methods to detect, analyze, and quantify the bacteria 
associated with periodontal health and disease from oral samples. These methods include 
microscopy, culturing, immunological assays, enzymatic tests, flow cytometry, 
checkerboard DNA-DNA hybridization, in situ hybridization, loop-mediated isothermal 
amplification, PCR, QPCR, 16S rRNA gene-based cloning methods, microarray, and next 
generation sequencing (Armitage et al. 1982; Loesche et al. 1990; Uematsu and Hoshino 
1992; Snyder et al. 1996; Socransky et al. 1998; Paster et al. 2001; Kumar et al. 2003; 
Boutaga et al. 2005; Colombo et al. 2007; Miyagawa et al. 2008; Colombo et al. 2009; 
Turunen et al. 2012; Liu et al. 2012).  
 Culturing methods are even nowadays considered as a gold standard in the 
characterization of oral samples, despite the development of molecular methods. A 
notable strength is the possibility to assess antibiotic sensitivity of the detected strains. 
Because the majority of periodontal disease-associated bacteria in subgingival sites are 
facultative or obligatory anaerobes, the development of anaerobic culturing techniques 
has been essential for the field (Uematsu and Hoshino 1992). Strict anaerobic precautions 
are also necessary during collection, transport, and processing of the samples. The 
bacteria have been cultured on selective or non-selective plates and media. The recovery 
of obligate anaerobes has been markedly enhanced by using the glove box system or 
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Hungate roll tube technique when compared to the conventional anaerobic jar technique 
(Arank et al. 1969; Gordon et al. 1971). 
 Advances in bacterial genome sequencing have facilitated the progression of 
DNA-based methodologies. Whole-genomic DNA probe hybridization in a “checkerboard” 
model enables the processing of a large number of oral samples and simultaneous 
detection of multiple bacteria (Socransky et al. 1994). Another widely used approach is the 
amplification of bacterial genes by single, nested, or multiplex PCR (Watanabe and 
Frommel 1993; Leys et al. 1994; Tran and Rudney 1996; Watanabe and Frommel 1996). 
The detection limit of PCR is usually from 101 to 102 and for DNA-DNA hybridization from 
103 to 104 bacterial cells. An attempt has been made to address the problem of 
enumerating the bacteria more efficiently than by culture and hybridization methods by 
employing QPCR. This potentially very sensitive and specific, and may be utilized for large 
numbers of samples. The QPCR assays for quantifying the periodontal pathogens are 
presented in Table 2.  
 The 16S rRNA-based cloning and sequencing methods have revealed excessive 
bacterial diversity in oral samples in health and disease (Paster et al. 2001; Hutter et al. 
2003; Kumar et al. 2005; Faveri et al. 2008). The results from these studies also 
demonstrate that less than 50% of bacteria found in subgingival plaques are currently 
cultivable (Paster et al. 2001; Faveri et al. 2008).  In addition to detecting new species, the 
method and analysis may be targeted at groups of interest. This approach has proven to 
be substantially more efficient in analyzing phylotype diversity than conventional 
“universal” primers (de Lillo et al. 2004; Moter et al. 2006; Vartoukian et al. 2009). The 
disadvantages of the 16S rRNA-based cloning and sequencing method include the relative 
slowness and cost, inadequate 16S rRNA-based identification of certain related species, 
and the inability to detect intra-specific genomic variation. The existing 16S rRNA data 
have been used in developing the Human Oral Microbe Identification Microarray 
(HOMIM), which includes 400 probes targeting >300 species. The detection limit of 
HOMIM is approximately ≥104 bacterial cells. (Colombo et al. 2009) Employment of high-
throughput sequencing methods is emerging and may provide an even broader 
identification spectrum and greater sensitivity than microarray analysis (Keijser et al. 2008; 
Lazarevic et al. 2009; Ahn et al. 2011; Liu et al. 2012). Additionally, direct sequencing 
evades the biases produced by conventional DNA extraction, PCR amplification, and 
cloning. However, these methods are focused on relative distributions at the phylum and 
genus levels instead of quantifying specific species, and are currently in not in diagnostic 
use. 
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Table 2. The QPCR assays for periodontal disease-associated bacteria. 
Study Detected species Sample specimen Target gene 
Shelburne et al. 2000 Tf SP 16S rRNA 
Lyons et al. 2000 Pg SP 16S rRNA/IRS 
Sakamoto et al. 2001 Aa, Pg, Td, Tf, Ts SP, saliva 16S rRNA 
Asai et al. 2002 Td, Tm, Tv SP 16S rRNA 
Martin et al. 2002 Fspp, Pm, Pg, Pssp Carious dentine 16S rRNA 
Boutaga et al. 2003 Pg SP 16S rRNA 
Morillo et al. 2003 Aa, Pg ATCC strains 
lktC, Arg-
gingipain 
Maeda et al. 2003 Aa, Pg, Pi SP 16S rRNA 
Yoshida et al. 2003 Aa, Pg SP, saliva lktA, 16S rRNA 
Rudney et al. 2003 Aa, Pg, Tf SP 16S rRNA 
Kuboniwa et al. 2004 Aa, Pg, Pi, Pn, Td, Tf 
SP, tongue surface 
debris 
16S rRNA 
Nonnenmacher et al. 2004 Aa, Dp, Pm, Pg, Pi SP 16S rRNA 
Morillo et al. 2004*  Tf SP BspA antigen 
Yoshida et al. 2004 Td SP 16S rRNA 
Suzuki et al. 2004 Fspp, Tf SP 16S rRNA 
Boutaga et al. 2005 Aa, Fspp, Pm, Pi, Tf SP 16S rRNA 
Nonnenmacher et al. 2005* Cr SP 16S rRNA 
Saygun et al. 2008 Aa, Cr, Fn, Pg, Pi, Tf  SP 
hgbA, csxA, 16S 
rRNA, fimA 
Abiko et al. 2010 
Aa, Cr, Es, Mt, Pg, Pi, 
Pt, Se, Tf 
SP 16S rRNA  
Decat et al. 2012† 
Aa, Fn, Pg, Pi, Pm, Td, 
Tf 
Bacterial strains 
waaA, waaG, 
16S rRNA  
Leishman et al. 2012 Aa, Fn, Pg, Tf  SP 16S rRNA 
* The other QPCR assays mentioned in the publication have been published earlier by the same 
group. † All primers have been published earlier by other groups.  Aa, Aggregatibacter 
actinomycetemcomitans; ATCC, American Type Culture Collection; Cr, Campylobacter rectus; Dp, 
Dialister pneumosintes; Es, Eubacterium saphenum; Fn, Fusobacterium nucleatum; Fspp, 
Fusobacterium spp; ISR, intergenic spacer region; Mt, Mogibacterium timidum; Pg, Porphyromonas 
gingivalis; Pi, Prevotella intermedia; Pm, Parvimonas micra; Pn, Prevotella nigrescens; Pspp, 
Prevotella spp; Pt, Prevotella tannerae; Se, Slackia exigua; SP, subgingival plaque; Tf, Tannerella 
forsythia; Td, Treponema denticola; Tm, Treponema medium; Ts, Treponema socranskii; Tv, 
Treponema vincentii.    
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1.5.4. Periodontal pathogens and ASVD 
 
Several individual seroepidemiological studies have associated an elevated serum 
antibody response against periodontal pathogens, mainly A. actinomycetemcomitans and 
P. gingivalis, with increased OR for carotid IMT, coronary artery calcification, atrial 
fibrillation, carotid artery atherosclerosis, prevalent CHD, stroke, fatal MI, and non-fatal 
MI (Pussinen et al. 2003; Pussinen et al. 2004; Pussinen et al. 2004; Pussinen et al. 2005; 
Beck et al. 2005; Beck et al. 2005; Pussinen et al. 2007; Pussinen et al. 2007; Lund Haheim 
et al. 2008; Colhoun et al. 2008). A meta-analysis by Mustapha et al., including three 
cohort and four cross-sectional studies, found a significant association between systemic 
markers of periodontitis and CHD with a combined OR of 1.75 (95% CI 1.32–2.34) 
(Mustapha et al. 2007). The oral colonization of putative periodontal pathogens has been 
linked with the ASVD outcome in eight studies (Table 3.). The results demonstrate the 
association between the acute coronary outcome and the abundance of P. gingivalis and T. 
forsythia (Dogan et al. 2005), the number of prevalent species and presence of P. 
intermedia and T. forsythia (Andriankaja et al. 2011), and the total bacterial burden 
(Dogan et al. 2005; Renvert et al. 2006) in subgingival plaque. A stable ASVD outcome is 
linked with the abundance and presence of A. actinomycetemcomitans and abundance of 
P. intermedia (Spahr et al. 2006; Nonnenmacher et al. 2007; Mäntylä et al. 2013), and the 
total bacterial burden (Spahr et al. 2006; Kawano and Cohen 2013). Subclinical 
atherosclerosis associates with the presence of P. gingivalis (Yakob et al. 2011; Bechmann 
et al. 2012) and the total bacterial burden (Desvarieux et al. 2005). In contrast, a recent 
study by Ismail et al. reported no differences in oral microbiota diversity in 16S rRNA-
sequenced subgingival plaque samples between 20 patients with severe atherosclerosis 
and 10 healthy controls (Winkel et al. 2012). 
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Table 3. Association of subgingival periodontal pathogens with ASVDs 
Study N 
Bacterial detection 
method 
ASVD 
outcome 
Association 
p <0.05 
Desvarieux et al. 
2005 
657 
DNA-DNA hybridization,  
11 species 
Carotid IMT 
TBB, causative 
bacterial burden, 
etiologic bacterial 
dominance  
Dogan et al. 
2005 
11 cases,  
11 controls* 
Culture, 6 species AMI 
TBB, mean 
numbers of Pg and 
Tf 
Spahr et al. 2006 
263 cases, 
526 controls 
DNA-DNA hybridization, 
5 species 
Stable CHD TBB, number of Aa  
Renvert et al. 
2006 
146 cases, 
120 controls 
DNA-DNA hybridization,  
40 species 
ACS  TTB  
Nonnenmacher 
et al. 2007 
45 cases,  
45 controls 
QPCR, 6 species CAD 
Mean numbers of 
Pi 
Andriankaja et 
al. 2011 
313 cases, 
747 controls 
Immunofluorescence 
microscopy, 6 species  
Non-fatal 
MI 
Number of species 
present,  presence 
of Pi and Tf 
Yakob et al. 
2011 
128 
Conventional PCR,  
5 species 
cIMA Presence of Pg 
Winkel et al. 
2012 
20 cases,  
10 controls 
16S rRNA-based cloning 
and sequencing 
Severe 
atheroscle-
rosis 
No association 
Mäntylä et al. 
2013 
171 CAD, 
158 ACS, 
116 no-CAD 
DNA-DNA hybridization, 
4 species 
CAD, ACS 
Presence of Aa 
with CAD 
* Both cases and controls have generalized chronic periodontitis. Aa, Aggregatibacter 
actinomycetemcomitans; ACS, acute coronary syndrome; AMI; acute myocardial infarction; ASVD, 
atherosclerosis vascular disease; CAD, coronary artery disease; CHD, coronary heart disease; cIMA, 
calculated intima-media area; IMT, intima-media thickness; MI, myocardial infarction; Pg, 
Porphyromonas gingivalis; Pi, Prevotella intermedia; TBB, total bacterial burden; Tf, Tannerella 
forsythia 
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 The association between periodontal pathogens and atherosclerosis has also 
been studied in vivo with experimental animal models. Most of the studies have been 
conducted in the apoE-deficient mouse model or its derivatives with P. gingivalis infection. 
Administration of P. gingivalis intravenously (Li et al. 2002; Hashimoto et al. 2006; Madan 
et al. 2007; Hayashi et al. 2011), orally (Lalla et al. 2003; Gibson et al. 2004), or 
intrasubcutaneously (Champagne et al. 2009) has been shown to accelerate the 
development of atherosclerosis in apoE-deficient mice. Additionally, similar results have 
been acquired with P. gingivalis LPS alone (Gitlin and Loftin 2009). Recently, Fukasawa et 
al. reported that the formation of atherosclerotic plaques was significantly increased 
among C57BL/6 mice that were repeatedly infected intravenously with P. gingivalis and 
received an atherogenic diet (Fukasawa et al. 2012). These phenomena are associated 
with the findings that P. gingivalis infection may induce a proatherogenic shift in the 
serum lipid profile (Maekawa et al. 2011), alter the systemic cytokine profile and vascular 
reactivity (Pereira et al. 2011; Miyauchi et al. 2012), increase advanced glycation 
endproducts and their receptor in aortic endothelial cells (Pollreisz et al. 2010), and induce 
aortic intimal hyperplasia (Hokamura et al. 2010). Prior immunization has been shown to 
prevent P. gingivalis-mediated atherosclerosis in mice (Miyamoto et al. 2006; Koizumi et 
al. 2008; Hayashi et al. 2011; Turunen et al. 2012). The proatherogenic effects of P. 
gingivalis have also been detected in New Zealand White rabbits on atherogenic diet (Jain 
et al. 2003), and in normocholesterolemic and hypercholesterolemic pigs (Brodala et al. 
2005).  
 Infection with A. actinomycetemcomitans has been shown to induce aortic MMP-
9 production, activation of aortic mast cells, and a proatherogenic shift in macrophage 
cholesterol homeostasis and the serum lipid profile in apoE-deficient mice (Tuomainen et 
al. 2008; Oksaharju et al. 2009; Tuomainen et al. 2011). Zhang et al. have demonstrated 
that intravenous inoculations with A. actinomycetemcomitans results in larger 
atherosclerotic plaques and increased aortic cytokine expression in apoE-deficient mice 
than in sham- or S. mutans-infected mice (Zhang et al. 2010). Jia et al. report in 2013 that 
A. actinomycetemcomitans infection increases lesions, ROS production, and the 
expression of PRRs (Jia et al. 2013). Recently, F. nucleatum and its hsp GroEL alone have 
also been demonstrated to induce accelerated atherogenesis in apoE-deficient mice on an 
atherogenic diet (Lee et al. 2012). 
 The mechanisms by which periodontal pathogens may contribute to the 
development of atherosclerosis include both direct and indirect interactions with vascular 
cells and other factors related to atherogenesis and adverse cardiovascular outcomes. 
Direct interactions include transient bacteremia and vascular infection. The periodontal 
microbiota has augmented access to the systemic circulation via inflamed gingival and 
periodontal tissue. The bacteria may disseminate directly after mastication, tooth 
brushing or other dental procedures and create transient bacteremia. In addition, they 
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may be phagocytosed by monocytes in periodontal tissue and dispersed within them. 
These hypotheses are supported by the multiple findings of periodontal pathogen DNA 
and even viable bacteria from atherosclerotic lesions (Haraszthy et al. 2000; Kozarov et al. 
2005; Fiehn et al. 2005; Gaetti-Jardim et al. 2009; Rafferty et al. 2011). Interestingly, 
periodontal bacteria DNA is mainly found in atherosclerotic and not in healthy tissue (Ott 
et al. 2006; Pucar et al. 2007). In vitro studies have demonstrated that periodontal 
pathogens are able to invade human vascular and aortic endothelial cells (HAECs), and 
SMCs (Deshpande et al. 1998; Dorn et al. 1999; Schenkein et al. 2000; Dorn et al. 2002). 
This invasion may be enhanced by polymicrobial infection with F. nucleatum as reported 
for P. gingivalis (Saito et al. 2008). Infection of vascular cells with fimbriated P. gingivalis 
activates the cells and increases the expression of MCP-1, ICAM-1, VCAM-1, E- and P-
selectin, IL-6, and IL-8 (Chou et al. 2005; Choi et al. 2005). The vascular ECs and whole 
blood cells are also activated by bacterial proteases, LPS, and free soluble surface material 
including GroEL-like protein (Inomata et al. 2007; Oscarsson et al. 2008). The infection 
may enhance EC apoptosis and SMC proliferation (Roth et al. 2007; Inaba et al. 2011). The 
persistence of P. gingivalis in vascular tissue is facilitated by cellular autophagy (Belanger 
et al. 2006) and intercellular spreading between different cell types (Li et al. 2008). 
Infection with P. gingivalis enhances monocyte/macrophage migration, the production of 
pro-inflammatory cytokines, and foam cell formation (Giacona et al. 2004; Pollreisz et al. 
2010). In addition, A. actinomycetemcomitans and P. gingivalis derived LPS alone 
augments foam cell formation and alters the expression of atherosclerosis-related genes 
(Lakio et al. 2006; Lei et al. 2011; Morishita et al. 2013). The innate immune system 
recognizes periodontal bacteria and their products via both TLR2 and TLR4 (Triantafilou et 
al. 2007; Kikkert et al. 2007; Gelani et al. 2009). Interestingly, the predominant 
proatherogenic pathway may be via TLR2 (Erridge et al. 2007), and the TLR4-mediated 
responses function in an atheroprotective manner (Hayashi et al. 2012). Periodontal 
bacteria are also able to activate platelets and mast cells, induce pro-coagulant and pro-
thrombotic effects, and enhance the production of fibrous cap-degrading MMPs 
(Kuramitsu et al. 2001; Roth et al. 2006; Oksaharju et al. 2009; Assinger et al. 2012). 
 Indirect interactions of periodontal pathogens in atherogenesis include systemic 
inflammation and molecular mimicry. Multiple studies have associated periodontal 
infection with proatherogenic serum lipoprotein and the FA profile, as well as augmented 
systemic inflammation markers, including CRP, LPS, TNF-α, and IL-6 (Loos et al. 2000; 
Noack et al. 2001; Pussinen et al. 2004; Pussinen et al. 2004; Papapanagiotou et al. 2009; 
Ramirez-Tortosa et al. 2010). Case-control studies support the association between 
systemic inflammation and the dyslipidemic status (Nibali et al. 2007; Buhlin et al. 2009), 
and periodontal treatment has been shown to induce beneficial changes in systemic ASVD 
risk marker levels (D'Aiuto et al. 2004; D'Aiuto et al. 2006; Tonetti et al. 2007; Buhlin et al. 
2009). The immune system may be alternatively disturbed due to cross-reactive 
antibodies generated by molecular mimicry. This phenomenon has been demonstrated, 
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for instance, between GroEL of P. gingivalis and autologous hsp60 (Ford et al. 2007), 
gingipain of P. gingivalis and malondialdehyde modified LDL (Turunen et al. 2012), A. 
actinomycetemcomitans and hsp60 (Alfakry et al. 2011), and oral bacterial 
phosphorylcholine and oxidized LDL (Schenkein et al. 2001).  
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2. AIMS OF THE STUDY 
 
The general aims of the thesis project were to investigate the role of periodontal disease-
associated bacteria in coronary artery disease, and the mechanisms by which common 
chronic infections promote proatherogenic alterations. 
The specific aims were: 
I. To investigate the effects of A. actinomycetemcomitans and C. pneumoniae 
infections on the hepatic inflammation status and lipid homeostasis in 
apolipoprotein E-deficient mice. 
II. To examine the effect of A. actinomycetemcomitans and C. pneumoniae infections 
on the adipose tissue transcriptomes and lipid homeostasis in apolipoprotein E-
deficient mice. 
III. To develop and validate a QPCR method to analyze the levels of A. 
actinomycetemcomitans, P. gingivalis, P. intermedia, T. denticola, and T. forsythia 
in saliva samples. 
IV. To determine the association between the quantitative periodontal pathogen 
burden in saliva and angiographically verified coronary artery disease.  
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3. MICE, STUDY SUBJECTS, AND METHODS 
 
3.1. Mice and study design (I, II) 
 
3.1.1. Mice (I, II) 
 
Male apoE-deficient mice (B6.129P2- Apoetm1Unc/Crl) (N = 59) were acquired from Charles 
River Laboratories, maintained in a germ-free environment at the National Public Health 
Institute Animal Facilities in Helsinki, Finland, and fed regular mouse chow ab libitum. 
Animal care and experiments were conducted under the ethical authorization Animal Care 
and Use Committee of the National Public Health Institute and were in accordance with 
the guidelines of the Council of Europe. The study was approved by the Regional State 
Administrative Agency (approval reference numbers STH390A, STU 230 A, and STU 434 A). 
 
3.1.2. Study design (I, II) 
 
The study design and infection procedure are presented in Table 4. Viable C. pneumoniae 
was inoculated intranasally using a single dose of 2 x 106 inclusion-forming units in 40 µl 
sucrose-phosphate-glutamic acid buffer (SPG). Viable A. actinomycetemcomitans was 
introduced intravenously into the tail vein, and a single dose comprised 1 x 107 colony 
forming units in 50 µl of 0.9% NaCl.  
 The 14-week experiment included three groups: 1) the Acute Cpn group (n = 7), 
with one C. pneumoniae inoculation at the age of 9 wks; 2) the Chronic Cpn group (n = 7), 
with three C. pneumoniae inoculations at the age of 9, 11, and 13 wks; and 3) the control 
group (n = 6), with three SPG inoculations at the age of 9, 11, and 13 wks. The mice were 
sacrificed at the age of 14 wks. The 24-week experiment included four groups: 1) the 
recurrent A. actinomycetemcomitans infection group (Aa group, n = 10), with ten  A. 
actinomycetemcomitans inoculations once a week from the age of 14 to 23 wks; 2) the 
chronic C. pneumoniae infection group (Cpn group, n = 10), with three C. pneumoniae 
inoculations at the age of 9, 11, and 13 wks; 3) the combined chronic C. pneumoniae and 
recurrent A. actinomycetemcomitans infection group (Cpn+Aa group, n = 10), with three C. 
pneumoniae inoculations at the age of 9, 11, and 13 wks, and ten A. 
actinomycetemcomitans inoculations once a week from the age of 14 to 23 wks; and 4) 
the control group (n = 9), with three SPG inoculations at the age of 9, 11, and 13 wks, and 
ten 0.9% NaCl inoculations once a week from the age of 14 to 23 wks. The mice were 
sacrificed at the age of 24 wks. 
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Table 4. Experimental design of the 14-week and 24-week mouse studies. 
Experiment 
type 
Study 
group 
Age (weeks) 
9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 
14-week 
study 
Acute Cpn 
group ▪     †           
Chronic 
Cpn group ▪  ▪  ▪ †           
Control □  □  □ †           
24-week 
study 
Cpn group ▪  ▪  ▪           † 
Aa group      ● ● ● ● ● ● ● ● ● ● † 
Cpn+Aa 
group ▪  ▪  ▪ ● ● ● ● ● ● ● ● ● ● † 
Control □  □  □ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ † 
The black squares represent Cpn inoculations and the black circles Aa inoculations. The controls 
received the respective vehicle (white squares and circles). †, sacrifice; Aa, A. 
actinomycetemcomitans; Cpn, C. pneumoniae. 
 
3.2. Study subjects (III, IV) 
 
3.2.1. Periodontally diseased and healthy subjects (III) 
 
The study subjects (n = 165) participated in the “Oral health in the Finnish adult 
population” study (n = 6335) (Knuuttila et al. 2008), a sub-study of the Health 2000 Health 
Examination Survey (N = 8028) coordinated by the National Public Health Institute in 
Finland (Aromaa et al. 2004). A subpopulation of 1294 subjects attended in interview, oral 
health examination, and saliva sample collection, and had their saliva samples analyzed 
for oral bacteria (Könönen et al. 2007). We selected 165 subjects who met the following 
inclusion criteria: 40–60 years of age, having at least 20 teeth, clinical data on oral health 
examination, conventional PCR data on salivary bacteria, and available saliva samples. 
Periodontally diseased subjects (n = 84) had at least 14 teeth with a probing pocket depth 
of ≥4 mm. Approximately 80% of diseased subjects had teeth with a probing pocket depth 
of ≥6 mm. Periodontally healthy subjects (n = 81) had no teeth with deepened pockets. 
The study conformed to the principles of the Declaration of Helsinki and was approved by 
the National Public Health Institute Ethics Committee. 
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3.2.2. Subjects with angiographically verified CAD, ACS, and non-CAD (IV) 
 
The study subjects (n = 492) were participants in the Parogene study, a sub-study 
comprising 506 patients from the first cohort of the Corogene study (Buhlin et al. 2011).  
The Corogene study is a prospective CAD cohort study conducted in Hospital District of 
Helsinki and Uusimaa in Finland (Vaara et al. 2011). The first cohort consists of 
symptomatic Finnish patients (N = 5295) assigned to coronary angiography for diagnostic 
purposes between June 2006 and March 2008 at Helsinki University Central Hospital in 
Finland. The random enrolment of the Parogene population involved 10% of the Corogene 
population; data on the cardiac condition were not available at that time. However, 
because women comprised approximately 30% of the first Corogene cohort, a similar 
gender distribution was also the goal in the Parogene study population. Within five 
months post-angiography, the enrolled patients (n = 567) were interviewed over the 
telephone by a specialized nurse; 508 participated in detailed clinical and radiographical 
oral examination including saliva sample collection, at the Institute of Dentistry, University 
of Helsinki, Finland. The thesis study cohort consisted of 179 patients with stable CAD, 166 
patients with ACS, 28 patients with ACS but no CAD, and 119 patients with normal or ≤50% 
obstructed arteries. The study conformed to the principles of the Declaration of Helsinki 
and was approved by the ethics committee of Helsinki University Central Hospital 
(approval reference number 106/ 2007). 
 
3.3. Methods 
 
3.3.1. Bacterial culture (I, II, III) 
 
A. actinomycetemcomitans clinical strain AT445b was grown in tryptic-soy-serum-
bacitracin-vancomycin medium (studies I and II) and reference strains ATCC 29523, ATCC 
43718, ATCC 33384, IDH 781, IDH 1705, CU 1000, and C59A were cultivated on Brucella 
agar plates (study III) with 5% (v/v) horse serum and incubated in 5% CO2 at 37 °C for 48 h. 
P. intermedia ATCC 25611, T. forsythia ATCC 43037, and P. gingivalis ATCC 33277, W50, 
OMGS 343 strains were cultivated on Brucella agar plates in anaerobic jars. T. denticola 
was received from Dr Howard Kuramitsu (State University of New York at Buffalo, USA). C. 
pneumoniae isolate Kajaani 7 was grown in HL cells. Purification was performed using a 
centrifugation-sonication-centrifugation cycle. The pellet was suspended in SPG and the 
stock was stored in SPG in -70°C. The number of inclusion forming units was determined 
by culture in HL cells by infecting the cells with serial dilutions of C. pneumoniae followed 
by incubation in 5% CO2 at 35 °C for 72 h. 
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3.3.2. Detection of bacteria in lung and liver tissues (I) 
 
Tissue DNA was extracted using a QIAamp Mini Kit (Qiagen). A. actinomycetemcomitans 
and C. pneumoniae were detected in lung and liver tissues by QPCR. A. 
actinomycetemcomitans was detected as described in section 3.3.9. QPCR-negative C. 
pneumoniae samples were analyzed by a semiconventional nested PCR. In nested PCR, the 
first PCR was conventional and outer primers were targeted at the PstI fragment and 
amplified 192 bp product. To prevent carryover contamination, dTTP was replaced by 
dUTP and heat-labile uracil-DNA N-glycosylase was added to the reaction. The following 
QPCR amplification was performed with the LightCycler instrument (Roche) detecting the 
128 bp product of the PstI fragment. The detection limits were 8 GE for C. pneumoniae 
and 21 GE for A. actinomycetemcomitans. 
 
3.3.3. Histological analysis and immunohistochemistry (I) 
 
Liver samples were fixed in 10% buffered formalin, embedded in paraffin, and cut into 5-
µm sections by microtomy. The sections were stained with hematoxylin and eosin using 
standard histological techniques. Hepatic morphology was evaluated by two blinded 
specialists using a light microscope. The emphasis was on fat accumulation and 
inflammation. The grading of the inflammatory changes was 0–4, where 0 represented 
incidental or minimal changes and 4 severe or extensive changes. The grading of 
microvesicular appearance was 0–4: 1, <25% of cells containing excess vesicles; 2, 26–50%; 
3, 51–75%; 4, >75%. Besides grading, the nature of the alterations, including the main 
inflammatory cell types and type of vacuolation, as well as their extent (focal to diffuse) 
was recorded. Additionally, the paraffin sections were stained using an immunoperoxidase 
procedure for CD68 and IL-1β. The dilution of CD68 antibody (SC-7084, Santa Cruz) was 
1:50 and that of IL-1β antibody (AF-401-NA, R&D Systems) was 1:100. The secondary 
antibody was biotinylated anti-goat IgG 1:200 (Vector Laboratories). The 
immunohistochemical staining was performed according to the manufacturer’s 
instructions. 
 
3.3.4. Liver lipid analysis (I) 
 
Frozen liver tissue (10 mg) was homogenized in 1.25 ml 1:2 methanol-chloroform using a 
Turrax homogenizer. The TGs were extracted by washing the 1 ml homogenate with NaCl, 
extracting the TGs into the chloroform phase, and dissolving the dried extract  in 200 µL of 
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tetraethyl ammonium hydroxide/95% ethanol (1:28). The extract was incubated at 60 °C 
for 30 min and subjected to hydrolysis by adding 200 µL 0.05 M HCl. The TGs were 
measured using the enzymatic glycerol-3-phosphate-oxidase-peroxidase-amidopyrine 
method (11488872, Roche). For cholesterol and phospholipids quantification, the 200 µl 
homogenate samples were briefly centrifuged and 200 µl of supernatant dried under 
nitrogen. After dissolving the extracts into 100 µl methanol the concentration of 
cholesterol was measured using the cholesterol oxidase-peroxidase-amidopyrine method 
(11489232, Roche) and choline-containing phospholipids by enzymatic calorimetric 
method (999-54006, Wako Chemicals GmbH). The inter-assay coefficient of variation was 
4.9% for TG, 2.9% for cholesterol, and 2.7% for the phospholipid assay. 
 
3.3.5. Tissue FA analysis (I, II) 
 
The total lipids were extracted with hexane-isopropanol (3:2) from 50–100 mg liver tissue 
and converted into FA methyl esters by heating with acidic methanol (5% H2SO4). The 
composition of the recovered methylated FAs was analyzed using a Hewlett Packard 6890 
GC gas-liquid chromatograph with Chemstation Rev. B.01.03. The capillary column was a 
30 m DB225 with a 0.32 mm inner diameter and a 0.25 mm phase layer (Agilent 
Technologies). Samples were split-injected with hydrogen as the carrier gas. The thermal 
program was from 160 °C to 230 °C. The distribution of methylated FAs was expressed as 
wt% normalized to 100%. The inter-assay coefficient of variation for FA peaks over 1% was 
2–7%. 
 
3.3.6. Isolation of RNA, synthesis of cDNA, and QPCR assays for relative quantification of 
mRNA expression (I, II) 
 
The liver and AT specimens were stabilized with RNAlater™ (Sigma) and the samples were 
stored at -70 °C. Liver and AT were homogenized using a Mixer Mill MM 301 (Retsch 
GmbH). The extractions of total RNA were performed using an RNeasy Mini Kit (Qiagen) 
and RNeasy Lipid Tissue Mini Kit (Qiagen). Genomic DNA contamination was removed by 
DNase treatment on a column using a RNase-Free DNase Set (Qiagen) and for AT 
additionally also using a DNA-free™ Kit (Ambion). The concentrations of RNA were 
measured using a NanoDrop 1000 (Thermo Scientific). Synthesis of liver and AT cDNA was 
performed from total RNA using an ImProm-II™ Reverse Transcription system (Promega). 
 Primers (Thermo Scientific) for ACC2, CD68, fatty acid synthase, glyceraldehyde-3-
phosphate dehydrogenase (Gapdh), IL-1β, LDLr, Mcp-1, macrophage migration inhibitory 
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factor (Mif), mannose receptor C type 1 (Mrc-1), Mpo, secretory leukocyte peptidase 
inhibitor (Slpi), and Srebp were designed with Beacon Designer (Premier Biosoft 
International) and the National Center for Biotechnology Information Primer-BLAST 
(http://www.ncbi.nlm.nih.gov/tools/primer-blast/). QPCR amplification was performed 
with an Mx3005 Real-Time QPCR System (Stratagene). The reaction mixture (12.5 µl) 
contained 2 µl of template DNA, 6.25 µl Brilliant SYBR® Green QPCR Master Mix 
(Stratagene), 30 nM ROX reference dye (Stratagene), and optimized concentrations of 
primers. The thermocycling program for amplification was as follows: initial denaturation 
at 95 °C for 15 min, 40 cycles of 15 s at 95 °C and 1 min at 60 °C. The melting curve analysis 
was 1 min at 95 °C, a gradual decrease to 55 °C, 30 s at 55 °C, a gradual increase to 95 °C, 
and 30 s at 95 °C. Analysis of the results was performed with Mx3005 Real-Time QPCR 
System (Stratagene) software and expressed as FCs to the respective control mice. The 
expression of Gapdh was used for normalization. The primer details are described in 
publications I and II. 
 
3.3.7. Saliva sample collection, isolation of bacterial DNA, and QPCR assays for 
periodontal pathogens (III, IV) 
 
Production of saliva was stimulated by paraffin and the samples were collected by 
expectoration. For analysis, 500 µl of saliva was centrifuged at 9300 g for 3 min and the 
pellet was suspended in 200 µl Tris-ethylenediaminetetraacetic acid buffer. The reference 
strain bacteria were carefully scraped from the plated and suspended in 200 µl Tris-
ethylenediaminetetraacetic acid buffer. Bacterial DNA was isolated using a ZR 
Fungal/Bacterial DNA Kit (Zymo Research) according to the manufacturer’s instructions.  
The kit was chosen according to its functional capacity in QPCR. 
 Primers and probes (Thermo Scientific and DNA Technology A/S) for A. 
actinomycetemcomitans, P. gingivalis, P. intermedia, T. denticola, and T. forsythia were 
designed with EPIMER3 software. QPCR amplification was performed with an Mx3005 
Real-Time QPCR System (Stratagene) and the samples were analyzed as duplicates. The 
reaction mixture (25 µl) contained 2 µl of template DNA, 12.5 µl Brilliant SYBR® QPCR 
Master Mix (Stratagene), 30 nM ROX reference dye (Stratagene), and optimized 
concentrations of primers. The thermocycling program for amplification was as follows: 
initial denaturation at 95 °C for 15 min, 40 cycles of 30 s at 95 °C and 1 min at 60 °C. 
Analysis of the results was performed with Mx3005 Real-Time QPCR System (Stratagene) 
software. The primer details are described in section 4.2.1. 
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3.3.8. Adipose tissue microarray analysis (II) 
 
The isolation of ATs RNA is described in section 3.3.6 and quality was assessed with an 
Agilent 2100 Bioanalyzer using a Eukaryote Total RNA Nano Kit (Agilent Technologies). The 
number of biological replicates was three. The amplification of high quality total RNA (RNA 
integrity number ≥8.5) was performed using an Illumina TotalPrep RNA Amplification Kit 
according to the manufacturer’s instructions and gene expression of ATs was analyzed 
using an Illumina Mouse WG-6 v2.0 platform. In gene ontology (GO) enrichment analysis, 
the significance of the differences between the experimental and control mouse groups 
were assessed by using the Fisher's exact test. Multiple hypotheses correction was 
performed using the Benjamini-Hochberg false discovery rate. 
 
3.3.9. CAD diagnosis and ASVD risk-related parameters (IV) 
 
The degree of coronary artery stenosis was evaluated by coronary angiography. According 
to the results, the patients were divided into four groups: 1) the “No significant CAD” 
group, comprising patients with normal or ≤50% obstructed coronary arteries; 2) the 
“Stable CAD” group, comprising patients with >50% stenosis in at least one coronary 
artery; 3) the “ACS” group, consisting of patients with >50% stenosis in at least one 
coronary artery, typical chest pain and electrocardiographic changes for ischemia, and 
elevated levels of cardiac biomarkers; and 4) the “ACS-like, no CAD” group, consisting of 
patients with ACS-like symptoms without significant (>50%) coronary artery obstruction. 
The patients completed a thorough questionnaire and the blood samples for CRP and 
other measurements were drawn from the arterial line during angiography. Weight was 
measured during hospitalization. Hypertension, dyslipidemia, and diabetes (type I and 
type II grouped together) were treated as dichotomous variables (yes/no) based on the 
patient’s status of having a prescription for the disorder. (Vaara et al. 2011) 
 
3.3.10. Statistical analyses (I, II, III, IV) 
 
In all studies, p-values <0.05 were considered statistically significant. In studies I and II, the 
results for normally distributed variables were expressed as the means with standard 
errors/deviations of the mean and for skewed variables as medians with interquartile 
ranges (IQRs). The statistical significance of the differences between the infected mice and 
the respective controls was analyzed using the non-parametric Mann-Whitney U-test. 
Two-tailed bivariate correlations were determined using Spearman’s test. Statistical 
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analyses were performed with the Statistical Package for Social Sciences version 15.0.1 
and PASW Statistics 18.  
 
 In study III, the variability in pathogen detection rates between the cases and the 
controls and the results from QPCR and conventional PCR methods were analyzed using 
the Pearson chi-squared test. The statistical significance of the differences between the 
cases and controls was analyzed using the non-parametric Mann–Whitney U-test. The 
diagnostic accuracy was assessed using Receiver Operating Characteristic (ROC) curve 
analysis. Statistical analyses were performed with the Statistical Package for the Social 
Sciences version 12.0.1.  
 
In study IV, the variation in study group characteristics was analyzed by one-way 
analysis of variance, the Kruskall–Wallis test, and the Pearson chi-squared test. Levels of 
pathogens and antibodies, and LPS activity were not normally distributed and were 
consequently expressed as medians with IQR. The significance of the differences between 
groups was analyzed using the non-parametric Mann–Whitney U-test with “No significant 
CAD” as the reference group. The pathogen burden and oral parameter association was 
analyzed using the Kruskal–Wallis test and the Jonckheere–Terpstra test for ordered 
alternatives. The two-tailed bivariate correlations were determined by using Spearman’s 
test. The pathogen and antibody values were transformed using log10 for the logistic 
regression models. The “ACS-like, no CAD” group was not included in logistic regression 
modeling due to the low number of patients (n = 28). The multi-factor model was adjusted 
for the following covariates: age, BMI, gender, hypertension, dyslipidemia, and smoking. 
The more detailed data are described in publication IV. Statistical analyses were 
performed with the PASW Statistics 18 and SAS® 9.2. 
  
  
52 
 
4. RESULTS AND DISCUSSION 
 
4.1. Infection and inflammation studies in apoE-deficient mice (I, II) 
 
The experimental design and infection procedure of mouse studies are presented in 
section 3.1.2. The results of combined infection model, the Cpn+Aa group, more closely 
resembled those of the Aa group than Cpn group, and are therefore presented and 
discussed in the context of A. actinomycetemcomitans infection in the thesis (I, II). The GO 
analysis results are presented for the 24-week study (II). Due to the relatively low number 
of mice in each study group, the statistical significance of differences between study 
groups and respective control groups were analyzed using the non-parametric Mann-
Whitney U-test. 
 
4.1.1. A. actinomycetemcomitans-induced hepatic inflammatory status (I)  
 
We detected intravenously inoculated A. actinomycetemcomitans by QPCR from the liver 
tissue of 30% of infected mice; the median level was 10 GE/mg liver tissue, with a range 
from 3 to 1654 GE/mg. The median level was relatively low, which might be due to the 
non-refined bacterial DNA isolation method. However, the positive detection results 
support the hypothesis that A. actinomycetemcomitans may disseminate into tissues via 
the circulation. The paraffin-embedded liver tissue sections were stained with 
hematoxylin/eosin and the morphology was evaluated and graded according to the 
observed level of infiltration of inflammatory cells and microvesicular appearance. The 
effect of A. actinomycetemcomitans infection on liver morphology was clearly 
proinflammatory. When compared to the controls, we observed an enhanced infiltration 
of inflammatory cells in both the Aa group (p = 0.002) and the combined infection model 
(Cpn+Aa group, p = 0.023). The phenomenon was particularly pronounced in the recurrent 
A. actinomycetemcomitans infection model (Figure 4).  
 Table 5 presents a summary of the studied parameters. The QPCR analyses on 
the relative expression of inflammation-related genes supported the observed increase in 
the inflammation status. The relative expression levels of Il-1β (p <0.001), Mcp-1 (p = 
0.008), and CD68 (p = 0.002) were higher in the Aa group, and the levels of Il-1β (p <0.001) 
in the Cpn+Aa group, than in control mice. The protein expression of Il-1β and CD68 was 
defined from immunohistochemical staining of liver paraffin sections.  
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Figure 4. Infiltration of inflammatory cells into liver tissue induced by recurrent A. 
actinomycetemcomitans infection.  The arrows point to examples of the sites affected. 
  
 The hepatic lipid concentrations were determined from chloroform-
methanol/methanol extracts of the frozen tissue samples. The phospholipid levels of liver 
tissue were significantly decreased among all infected mice. The reduction was especially 
substantial in the Aa group (mean ± standard error of mean [SEM]; 19.5 ± 2.2 mmol/mg 
tissue, p <0.001) when compared to control mice (88.9 ± 4.3 mmol/mg tissue). This may 
result from endotoxin activation of phospholipases 1A and 2A, and cause marked changes 
in membrane structure and function (Liu et al. 1988). Apart from the phospholipid 
reduction, the other measured parameters involved in lipid homeostasis were scarcely 
altered (Table 5). There were no significant changes in hepatic cholesterol and TG levels; 
however, the TG/cholesterol ratio was increased 4-fold in the Aa group (p <0.001). Lipid 
and lipoprotein metabolism-related gene expression was similar to that of control mice. 
Furthermore, the hepatic proportions of SFAs, monounsaturated fatty acids (MUFAs), and 
polyunsaturated fatty acids (PUFAs) remained unaltered. Moreover, the infection did not 
modify the serum lipid and lipoprotein metabolism-related factors. However, the TG levels 
were decreased (p = 0.041) in the Aa group.   
 The serum TNF-α concentration (p = 0.027) and LPS activity were higher (p = 
0.014) in the Aa group compared to the controls. Additionally, the level of serum 
immunoglobulin (Ig) G class antibodies against A. actinomycetemcomitans was 
significantly increased among all Aa-infected mice, and exhibited a positive correlation 
with the degree of hepatic inflammation. The observed changes in serum parameters 
were related to the augmented systemic inflammation reaction and resembled the results 
from other A. actinomycetemcomitans mouse studies (Tuomainen et al. 2008; Zhang et al. 
2010). The detection of A. actinomycetemcomitans from the liver tissue, combined with 
the infiltration and distribution of PBMC and neutrophils, up-regulated expression of 
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inflammation-related genes, and decreased levels of hepatic phospholipids, also indicated 
local infection-derived inflammation in the liver. It is reasonable to hypothesize that 
prolonged inflammation induces the production of ROS and proinflammatory cytokines, 
and may lead to ER stress, an unfolded protein response and hepatic injury. The 
administration of proteases and E. coli LPS in the gingival sulcus have been shown to 
induce hepatic inflammation and steatosis in rats (Tomofuji et al. 2007). The undetected 
hepatic steatosis in our study may be explained by the differences in bacterial stimuli and 
dosage. The recent A. actinomycetemcomitans mouse models demonstrating increased 
atherosclerotic lesions and an enhanced oxidation potential have used high bacterial 
doses and inoculations three times per week (Zhang et al. 2010; Jia et al. 2013). Our A. 
actinomycetemcomitans infection model more closely resembles repeated recurrent 
infections than an aggressive infection with continuous bacterial distribution.      
 Contrary to the pathogen burden hypothesis (Zhu et al. 2000; Georges et al. 2003), 
the combined infection model (Cpn+Aa group) did not result in cumulative or augmented 
infection-derived alterations. The systemic inflammation reaction and responses in the 
liver were milder than in the Aa group, and it seems that the C. pneumoniae infection may 
have primed the immune system.    
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Table 5. Studied parameters among A. actinomycetemcomitans-infected mice 
 Parameter 
Changes when compared to 
the control group, p  <0.05 
Aa group,  
n = 10 
Cpn+Aa 
group, n = 10 
 
Liver 
Infiltration of inflammatory cells ↑ ↑ 
Il-1β (mRNA FC) ↑ ↑ 
Mcp-1 (mRNA FC) ↑ - 
CD68 (mRNA FC) ↑ - 
Srebp-1c (mRNA FC) - - 
Fasn (mRNA FC) - - 
Acc2 (mRNA FC) - - 
LDLr (mRNA FC) - - 
Phospholipid (mmol/mg tissue) ↓ ↓ 
Cholesterol (mmol/mg tissue) - - 
TG (mmol/mg tissue) - - 
TG/cholesterol ↑ - 
SFA (%/total FAs) - - 
MUFA (%/total FAs) - - 
PUFA (%/total FAs) - - 
Serum 
TG (µmol/ml) ↓ - 
Cholesterol(µmol/ml) - - 
FFA (mg/dl) - - 
apoA-I (mg/ml) - - 
PLTP activity (µmol/ml/h) - - 
Adiponectin (ng/ml) - - 
LPS activity (EU/ml) ↑ - 
LBP (µg/ml) - - 
SAA (µg/ml) - - 
TNF-α (pg/ml) ↑ - 
IgG against  
A. actinomycetemcomitans (AU) 
↑ ↑ 
↑, increased/up-regulated; ↓, decreased/down-regulated; -, no change; Aa group, recurrent A. 
actinomycetemcomitans infection; Acc2, acetyl-CoA carboxylase 2; AT, Cpn+Aa group, combined 
recurrent A. actinomycetemcomitans and chronic C. pneumoniae infections; FA, fatty acid; Fasn, 
fatty acid synthase; FC, fold change; FFA, free fatty acid; Il-1β; interleukin 1β; LBP, LPS binding 
protein; LDLr, LDL receptor; LPS, lipopolysaccharide; Mcp-1, monocyte chemoattractant protein 1; 
MUFA, monounsaturated fatty acid; PLTP, phospholipid transfer protein; PUFA, polyunsaturated 
fatty acid; SAA, serum amyloid A;  SFA, saturated fatty acid; Srebp-1c, sterol responsive element 
binding protein 1c; TG, triglyceride; TNF-α, tumor necrosis factor α. 
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4.1.2. A. actinomycetemcomitans-derived changes in transcriptomes and fatty acid 
distribution in inguinal and epididymal adipose tissues (II) 
 
A summary of A. actinomycetemcomitans-derived changes in GO analysis, QPCR and FA 
distribution results in inguinal and epididymal AT depots is presented in Table 6. The 
serum parameters are presented in the previous section 4.1.1 in Table 5.   
 The transcriptomes of inguinal and epididymal AT were analyzed using the 
Illumina Mouse WG-6 v2.0 platform. The GO enrichment analysis revealed that humoral 
inflammation-related functional categories “Antigen binding” and “Antibacterial humoral 
response” were significantly enriched in both inguinal and epididymal AT depots among all 
A. actinomycetemcomitans-infected mice. In the Aa group the most up-regulated genes in 
the microarray analysis of inguinal AT were S100 calcium binding protein A8 (FC = 13.27) 
and lactotransferrin (FC = 6.62), and the QPCR analysis demonstrated up-regulated 
relative expression of Mpo (FC = 4.3, IQR 2.6, p = 0.009) and secretory leukocyte peptidase 
inhibitor (Slpi, FC = 4.7, IQR 3.0, p = 0.003). The respective gene products possess anti-
inflammatory and anti-microbial properties and are closely associated with the innate 
immune responses and especially the activation of neutrophils. Myeloid cell-derived Mpo, 
lactotransferrin, and S100 calcium binding protein A8 generate ROS and promote 
oxidative responses (Jacobsen et al. 2008; Pouliot et al. 2008; Ward et al. 2008). However, 
we did not observe changes in the relative expression of mannose receptor C type 1 (Mrc-
1) or CD68 mRNA indicating that the excess infiltration of macrophages remained absent 
and the ratio of classically or alternatively activated macrophages unaltered. These 
phenomena are typical in the low-grade inflammation associated with adiposity and the 
development of insulin resistance (Xu et al. 2003; Weisberg et al. 2003).  
 The effect of A. actinomycetemcomitans infection on the epididymal AT depot in 
the Aa group was quite different. Even though the pathways relating to humoral immunity 
responses were enriched, the up-regulation of neutrophil-derived defense reaction-
associated genes remained undetectable in the microarray and QPCR analyses. However, 
the “Monocarboxylic acid metabolic process” pathway was enriched (p = 0.006), and 
transcriptome data included several up-regulated de novo lipogenesis-associated genes: 
pyruvate carboxylase (FC = 2.82), fatty acid synthase (FC = 1.81), ELOVL family member 6, 
elongation of long chain fatty acids (FC = 3.21), and stearoyl-coenzyme A desaturase 2 (FC 
= 2.15). The AT de novo lipogenesis capacity is higher among rodents than humans, and 
our results indicate that it may be activated by inflammation (Letexier et al. 2003). The 
elevated serum and AT TNF-α levels promote insulin resistance (Hotamisligil et al. 1993; 
Olson et al. 2012), and this could further activate the de novo lipogenesis transcription 
factors, as observed in the liver.  
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Table 6. Summary of A. actinomycetemcomitans-derived changes in adipose tissue GO 
enrichment, QPCR, and FA distribution results 
 Parameter 
Changes when compared to the control group, 
p  <0.05 
Aa group* Cpn+Aa group* 
Inguinal 
AT 
Epididymal 
AT 
Inguinal 
AT 
Epididymal 
AT 
GO-enriched 
functional 
category  
Protein binding ↑ ↑ ↑ ↑ 
Antigen binding ↑ ↑ ↑ ↑ 
Antibacterial humoral 
response 
↑ ↑ ↑ ↑ 
Monocarboxylic acid 
metabolic process 
- ↑ - - 
Tissue development - - ↓ - 
Growth - - ↓ - 
QPCR 
analysis 
Mcp-1(mRNA FC) - (↓) (↓) (↓) 
Mrc-1 (mRNA FC) - - - - 
CD68 (mRNA FC) - - - - 
Mif (mRNA FC) - (↓) - (↓) 
Slpi (mRNA FC) ↑ (↓) - - 
Mpo (mRNA FC) ↑ ND - ND 
FA 
distribution 
SFA (%/total FAs) ↑ ↑ ↑ - 
MUFA (%/total FAs) - - - - 
PUFA (%/total FAs) ↓ ↓ ↓ ↓ 
PUFA/SFA ratio ↓ ↓ ↓ ↓ 
↑, increased/up-regulated; (↓), minor down-regulation; ↓, decreased/down-regulated; -, no 
change; *, the number of biological replicates was 10, except in GO analysis 3; Aa group, recurrent 
A. actinomycetemcomitans infection; AT, adipose tissue; Cpn+Aa group, combined recurrent A. 
actinomycetemcomitans and chronic C. pneumoniae infections; FA, fatty acid; FC, fold change; GO, 
gene ontology; Mcp-1, monocyte chemoattractant protein 1; Mif, macrophage migration 
inhibitory factor; Mpo, myeloperoxidase; Mrc-1, mannose receptor C type 1; MUFA, 
monounsaturated fatty acid; ND, not detected; PUFA, polyunsaturated fatty acid; SFA, saturated 
fatty acid; Slpi, secretory leukocyte peptidase inhibitor 
  
 Both inguinal and epididymal AT depot transcriptomes of the combined infection 
model, the Cpn+Aa group, exhibited enrichment in the “Protein binding” functional 
category (p <0.001), which involved multiple up-regulated immunoglobulin variables. The 
genes included in enriched “Tissue development” and “Growth” pathways were down-
regulated in the inguinal AT depot. The epididymal AT transcriptome analysis 
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demonstrated enrichment in the “Cell death” functional category (p = 0.016) including up-
regulated expression of metallothionein 3 (FC = 4.25) and arachidonate 12-lipoxygenase 
(FC = 3.91). Arachidonate 12-lipoxygenase catalyzes the formation of bioactive lipid 
mediator, 12-hydroxyeicosatetraenoic acid, from arachidonic acid.   
 A general observation from the GO enrichment analysis is that A. 
actinomycetemcomitans infection alters the AT transcriptomes in a depot-specific manner.  
Although enhanced “Humoral immune response” and “Antibody binding” functional 
categories were detected among all infected mice, the other responses varied. This is 
further supported by the results from QPCR analysis showing marked differences in 
relative gene expression levels between the inguinal and epididymal AT depots. The 
heterogeneity between AT depot characteristics has received increased attention within 
the past decade and it has been noticed that the depots associate differently with 
metabolic complications (Lee et al. 2012). In humans, visceral AT is associated with 
metabolic syndrome and differs from subcutaneous AT morphologically and functionally 
(Wajchenberg et al. 2002; Matsuzawa 2008). In mice, the depots differ in protein content 
and adipocyte size, and the basal levels of TG turnover and oxidative stress have been 
reported to be lower in inguinal AT than in epididymal AT in C57BL/6J mice (Sackmann-
Sala et al. 2012). Our results indicate heterogeneity in the response to recurrent infection, 
and inguinal AT appeared to be prone to inflammation-related responses, whereas in 
epididymal AT the de novo lipogenesis-related genes were up-regulated.        
 Distinctively, we observed notable changes in AT FA distribution and the 
responses were largely similar between different AT depots (Table 6). The A. 
actinomycetemcomitans infection markedly altered the fatty acid distribution in AT depots: 
the proportion of SFAs was higher in inguinal AT (p = 0.027) and epididymal AT (p = 0.003) 
in the Aa group, and in inguinal AT (p = 0.009) in the Cpn+Aa group compared to control 
mice (Table 6). The MUFAs remained unaltered; however, the proportion of PUFSs was 
significantly decreased in both AT depots among all A. actinomycetemcomitans-infected 
mice. These phenomena resulted in lowered ratios of PUFA/SFA in AT depots. The 
proportions of PUFA were inversely associated with serum LPS activity (p = 0.045 in 
inguinal AT; p = 0.013 in epididymal AT) which correlated positively with the serum FFA 
concentration (p <0.001). Adipocyte-released SFAs are known to be natural ligands for 
TLR4 and may activate macrophages facilitating the production of proinflammatory 
cytokines (Suganami et al. 2007). Both LPS and SFA are also able to generate ER stress in 
AT, which may be followed by metabolic disturbances such as the unfolded protein 
response and activation of degradation pathways (Alhusaini et al. 2010). The A. 
actinomycetemcomitans infection-induced increase in the proportion of SFA may augment 
the proinflammatory potential of AT depots. This may be further promoted by the 
observed reduction of PUFAs, because PUFAs potentially inhibit SFA-stimulated TLR 
dimerization (Lee et al. 2004). 
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4.1.3. The effect of C. pneumoniae infection on liver and adipose tissue lipid 
homeostasis and the adipose tissue transcriptome (I, II)  
 
We detected C. pneumoniae in the lungs of all intranasally infected mice in the 14-week 
study by QPCR. There were marked differences in the median pathogen levels: acute 
infection resulted in approximately 25000 chlamydial genome equivalents (GE)/mg lung 
tissue and chronic infection in 300 GE/mg lung tissue. The difference indicates that the 
two distinct infection models, acute versus chronic, had the desired outcomes in the lungs. 
In addition, we managed to detect C. pneumoniae in the liver tissue by non-quantitative 
semiconventional PCR. The prevalence was 29% in the acute model and 14% in the chronic 
model. The detection rates were decreased ten weeks after the last inoculation (24-week 
study) and were 55% in the lung and 0% in the liver, which may indicate partial clearance 
of the bacteria. It has been shown that after peritoneal acute C. pneumoniae infection, the 
viable bacteria are detectable in liver tissue and especially in Kupffer cells from 7 to 10 
days post-infection, but not on day 20 (Marangoni et al. 2006). Our findings support these 
results and the general hypothesis that C. pneumoniae is able to disseminate from the 
original infection site and infect other tissues (Airenne et al. 1999; Kalayoglu et al. 2002). 
 When evaluating the morphological changes we observed that chronic C. 
pneumoniae infection induced a significant increase in microvesicular formation in both 
the 14-week study (p = 0.007) and 24-week study (p = 0.001) when compared to the 
respective control mice. A representative picture of the microvesicular appearance is 
presented in Figure 5.  
 
 
Figure 5. Hepatic microvesicular appearance induced by chronic C. pneumoniae infection in the 
14-week study. The arrows point to examples of the sites affected. 
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 There were no histological inflammatory changes in the 14-week study; however, 
the microvesicular changes in the 24-week study were accompanied by moderate 
infiltration of inflammatory cells (p = 0.017). Acute C. pneumoniae infection up-regulated 
the relative expression level of IL-1β (mean fold change [FC] ± SEM, p-value; 3.9 ± 1.1, 
0.002), MCP-1 (2.8 ± 0.8, 0.004), and CD68 (3.2 ± 0.5, 0.002), and serum levels of serum 
amyloid A (SAA) were increased (p = 0.003) 
 The relative expression of the studied lipid and lipoprotein metabolism-related 
genes, including Srebp-1c, fatty acid synthase, Acc2, and LDLr remained unaltered among 
C. pneumoniae-infected mice. However, the hepatic phospholipid concentrations were 
significantly lower among all infected mice when compared to the respective controls. The 
same phenomenon was observed among A. actinomycetemcomitans-infected mice and 
may, as discussed before, derive from LPS stimulation of phospholipases 1A and 2A, and 
result in substantial disorder in the tissue (Liu et al. 1988). In addition, acute infection 
resulted in a markedly decreased level of hepatic TGs (mean mmol/mg tissue ± SEM; 13.4 
± 2.8 versus 31.3 ± 2.5 in controls, p = 0.001), and the TG/cholesterol ratio was thereby 
also reduced (p = 0.002). The proportion of SFAs showed an initial increase after C. 
pneumoniae infection and a gradual decrease over time: SFAs were higher in acute 
infection (p = 0.010), unchanged in chronic infection in the 14-week study (p = 0.317), and 
lower in chronic infection in the 24-week study (p = 0.006) compared to control mice. A 
somewhat opposite trend was observed for MUFAs (data not shown). Additionally, acute 
infection induced an increased hepatic proportion of proinflammatory arachidonic acid (p 
= 0.007), which may have derived from the possible LPS activation of phospholipases, and 
reduced PUFAs (p = 0.022). The PUFAs showed an inverse correlation with hepatic 
inflammation (p = 0.026).  
 The hepatic response of acute C. pneumoniae-infected mice strongly associated 
with enhanced inflammation. The pathogen was detected at high levels from the lungs 
and also found in the liver, and the serum level of acute phase response-related SAA was 
consequently increased and the relative hepatic expression of proinflammatory molecules 
mRNA was strongly up-regulated. The lipid alterations promoted the proinflammatory 
condition: hepatic phospholipids, TGs, and PUFAs were decreased, and SFAs and 
arachidonic acid were simultaneously increased. The situation markedly changed when 
progressing to chronic inflammation. C. pneumoniae was no longer detected in the liver; 
however, the liver morphology was altered and microvesicular formations were found. 
The FA profile differed from that of acute infection, showing lower relative SFA and higher 
MUFA proportions. The level of phospholipids remained low, which suggests that infection 
may lead to a lasting reduction in cell membrane phospholipids. This phenomenon has 
been reported earlier in a virus-induced steatohepatitis mouse model (Bingen et al. 1992), 
and may lead to severe dysfunction due to altered membrane fluidity, signaling, and 
topology properties. The liver is very important in the first line defense against bacterial 
61 
 
infections (Van Amersfoort et al. 2003), and our results suggest that C. pneumoniae 
infections are potent effectors in liver inflammation and lipid homeostasis. Interestingly, 
men diagnosed with steatohepatitis exhibit a high seroprevalence for IgA-class antibodies 
against C. pneumonia (Bolukbas et al. 2005).   
 The C. pneumoniae infection-derived alterations in AT tissue were less 
pronounced than in A. actinomycetemcomitans infection. In inguinal AT, the QPCR 
analyzed relative gene expression levels of Mcp-1, Mrc-1, CD68, Mif, Slpi, and Mpo 
remained unaltered. The transcriptome analysis revealed significant enrichment in 
development- and morphogenesis-related pathways. The distribution of FAs remained 
stable, except that the proportion of MUFAs was higher among infected mice compared to 
controls. In the epididymal AT depot, the C. pneumoniae infection induced enrichment of 
the “Defense response” (p = 0.003) including up-regulation of β-defensins 22, 29, 36, and 
38, and two cytokines. The functional categories “Very long-chain fatty acid metabolic 
process” (p = 0.003), “Long-chain fatty acid metabolic process” (p = 0.003), and “Long-
chain fatty acid-CoA ligase activity” (p = 0.001) were enriched and included up-regulated 
FATP2 (FC = 3.09). However, when compared to controls, the only difference in epididymal 
AT depot FA distribution was detected in the PUFA/SFA ratio which was decreased. 
Additionally, there were no changes in the relative gene expression levels of Mcp-1, CD68, 
Mif, Slpi, or Mpo, and only minor up-regulation in Mcr-1. These results suggest that the 
effects of C. pneumoniae infection focus more on the liver. The observed enrichments in 
functional categories failed to induce any relevant changes in the parameters studied in 
the thesis, and require further analysis. 
 
4.1.4. Limitations of the experimental mouse model studies (I, II) 
 
The mouse model used and gender are general considerations in mouse studies. As 
described in section 1.1.4, the major drawback in apoE-deficient mice is the complete 
absence of apoE, which possesses a range of important functions. Accordingly, apoE 
deficiency leads to a lipoprotein profile in which most of the cholesterol is in VLDLs instead 
of in LDLs, as in humans. In addition, extrapolating the results from mouse studies to 
human disorders is complicated, because there are several major differences between 
mouse and human immunology and lipoprotein metabolism, such as the absence of CETP 
and predominance of leukocytes in mice (Mestas and Hughes 2004). However, apoE-
deficient mice have been widely used in cardiovascular research, and also in a study of 
diet-induced steatohepatitis (Tous et al. 2005). In addition, the absence of apoE makes the 
mice more susceptible to LPS-derived alterations and thereby more “human-like” than 
rodents are in general. Regarding gender, we can draw only male-specific conclusions 
from our results. In mice, 13% of hepatic and 20% of AT genes exhibit sexual dimorphism 
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at the FC level >1.2, and the “Lipid metabolism” functional category is enriched at the FC 
level >3 in both tissues (Yang et al. 2006). However, the male homozygous apoE-deficient 
mice with a C57BL/6J genetic background used in the thesis project seem to be the most 
prone to atherosclerosis and generally less heterogeneous than female mice (Paigen et al. 
1987; Surra et al. 2010). In the AT microarray analysis, the main limitation was the number 
of biological replicates. 
 
4.2. Quantitative salivary pathogen level and coronary artery disease (III, IV) 
 
The periodontal disease-associated pathogens studied in the thesis project belong to the 
normal oral flora and are also detected among periodontally healthy subjects (Könönen et 
al. 2007). However, the levels of disease-associated bacteria are higher among subjects 
with periodontitis (von Troil-Linden et al. 1995; Haffajee et al. 1998) and it can be 
hypothesized that high levels of disease-associated bacteria enhance tissue destruction 
and facilitate the systemic distribution of bacteria. This potentially also affects the 
subsequent adverse implications in atherogenesis.   
 
4.2.1. Development and evaluation of QPCR assays for periodontal bacteria (III) 
 
Our goal was to develop a method to detect and enumerate five periodontal disease-
associated bacteria from saliva samples. The primers and Taqman probes were designed 
to detect single-copy hexose transferase genes in the LPS-coding region: waaA for A. 
actinomycetemcomitans, P. gingivalis, P. intermedia, and T. forsythia, and waaG for T. 
denticola (Table 7). QPCR is a sensitive method, and bacterial DNA isolation has a large 
impact on the results. We tested and evaluated several isolation methods and commercial 
kits (data not shown) when developing our assay. The optimized reactions were amplified 
using the Mx3005P Real-Time QPCR System (Stratagene). The analytical sensitivity of 
primer/probe sets was defined using serial dilutions of reference strains. The standard 
curve genome equivalents (GE) were calculated from respective bacterial genome sizes 
(the target gene copy number was one), and the sample GE numbers were generated 
from the standard curves. The detection limit ranged from 21 to 34 GE/2 µl of template 
DNA and reaction efficiencies from 87 to 96% in 101 to 105 serial dilutions. The specificities 
of the primer/probe sets were validated in silico using the Basic Local Aligment Tool and in 
vitro analysis of cross-reaction with 49 bacterial strains typically found in the oral cavity. In 
addition, the ability of A. actinomycetemcomitans assays to detect different serotypes was 
confirmed with strains representing serotypes a, b, c, d, e, f, and one non-serotypeable 
strain. The P. gingivalis assay was tested with serotypes a, b, and c. The results 
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demonstrated that the developed assays were sensitive and specific to the target species, 
yet able to detect different serotypes in the case of A. actinomycetemcomitans and P. 
gingivalis. In addition, they were robust over wide concentration ranges of bacterial DNA. 
 
Table 7. The primers and probes in the QPCR assay. 
Pathogen Primer and probe details 
Reference 
sequence 
A. actinomycetem- 
comitans 
Forward primer 5’–3’ 
Reverse primer 5’–3’ 
Probe 5’–3’ 
GCGAACGTTACGCGTTTTAC 
GGCAAATAAACGTGGGTGAC 
AATTGCCCGCACCGAAACCCAAC 
HK1651a 
P. gingivalis 
Forward primer 5’–3’ 
Reverse primer 5’–3’ 
Probe 5’–3’ 
TGGTTTCATGCAGCTTCTTT 
TCGGCACCTTCGTAATTCTT 
CGTACCTCATATCCCGAGGGGCTG 
PG1370b 
P. intermedia 
Forward primer 5’–3’ 
Reverse primer 5’–3’ 
Probe 5’–3’ 
GACCCGAACGCAAAATACAT 
AGGGCGAAAAGAACGTTAGG 
AAAGAAGGAACACCCCGACT 
PI0409b 
T. denticola 
Forward primer 5’–3’ 
Reverse primer 5’–3’ 
Probe 5’–3’ 
CCTTGAACAAAAACCGGAAA 
GGGAAAAGCAGGAAGCATAA 
GAGCTCTGAATAATTTTGATGCA 
TDE1427b 
T. forsythia 
Forward primer 5’–3’ 
Reverse primer 5’–3’ 
Probe 5’–3’ 
CTCGCTCGGTGAGTTTGAA 
ATGGCGAAAAGAACGTCAAC 
CGATTCGCAAGCGTTATCCCGACT 
TF29311b 
a, Actinobacillus Genome Sequencing Project; b, Los Alamos National Laboratory Oral Pathogen 
Sequence Database 
 
 Validation of the developed assays was performed by using a case-control 
population: saliva samples from periodontally diseased (n = 84) and healthy subjects (n = 
81). General details of the study population are presented in section 3.2.1. All studied 
bacteria were detected among both cases and controls, which resembles the observations 
in earlier studies (Socransky et al. 1998; Shelburne et al. 2000; Kuboniwa et al. 2004; 
Nonnenmacher et al. 2004; Könönen et al. 2007). The rates were significantly higher 
among the diseased compared to the healthy subjects: the prevalence rates varied from 
43% for A. actinomycetemcomitans to 94% for T. forsythia among cases and from 26% for 
A. actinomycetemcomitans to 68% for T. forsythia among controls. In addition, when 
compared to the periodontally healthy, the median levels of P. gingivalis were up to 37-
fold (p <0.001), P. intermedia 7-fold (p = 0.006), and T. forsythia 3-fold (p = 0.014) higher 
among the periodontally diseased. In general, the total median bacterial burden was 20-
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fold higher among cases (p <0.001), clearly demonstrating the role of the bacterial burden 
in periodontal disease. The validation was continued by diagnostic accuracy analysis of the 
assays, which was performed using ROC analysis (Table 8). All quantified pathogen levels 
were able to separate the cases and controls from each other and resulted in ROC areas 
under curve (AUC) >0.5. The highest diagnostic accuracy was observed with the total 
bacterial burden, with an AUC of 0.82, 95% confidence interval (CI): 0.76–0.87 and p 
<0.001. Out of the studied bacteria, the level of P. gingivalis was the most prominent 
diagnostic tool for periodontal disease, with an AUC of 0.75, 95% CI: 0.68–0.82, and p 
<0.001. This result parallels those in other studies demonstrating P. gingivalis as a highly 
potent periodontal pathogen (Bostanci and Belibasakis 2012). The overall results from 
ROC analyses indicate that the developed QPCR assays are sensitive and specific and may 
function as a potential diagnostic tool. However, evaluation of the “critical destructive 
bacterial level” requires further studies. 
 
Table 8. ROC analysis of diagnostic accuracy 
Pathogen level 
Area under the ROC curve  
(95% CI) 
p-value 
A. actinomycetemcomitans 0.60 (0.51–0.69) 0.028 
P. gingivalis 0.75 (0.68–0.82)  <0.001 
P. intermedia 0.67 (0.59–0.75)  <0.001 
T. denticola 0.60 (0.52–0.69)  0.024 
T. forsythia 0.71 (0.63–0.79)  <0.001 
Total pathogen burden 0.82 (0.76–0.89)  <0.001 
The number of periodontally diseased subjects was 84 and periodontally healthy was 81 in the 
analysis. CI, confidence interval; ROC, Receiver Operating Characteristic. 
 
 The oral microbiota comprises more than 600 species (Paster et al. 2006) and the 
number of documented bacteria associated with periodontal disease has been increasing 
alongside the development of molecular methods as described in section 1.5.1. From the 
chosen bacteria in our study, P. gingivalis, T. denticola, and T. forsythia belong to the 
classical “Red complex” and have demonstrated a strong association with periodontal 
disease. P. intermedia belongs to the second “Orange complex” and A. 
actinomycetemcomitans is strongly linked with aggressive periodontitis among the 
adolescent population. (Socransky et al. 1998; Haubek et al. 2001) The results from ROC 
analysis support the choice of bacteria, as all assays proved to be diagnostically valid.  
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 The enumeration and characterization of bacteria in oral samples has been a 
major goal in numerous studies (Moore et al. 1983; Socransky et al. 1998; Nonnenmacher 
et al. 2004). However, all methods have their subjective limitations. The obvious 
disadvantages when enumerating and characterizing periodontal microbiota by culturing 
methods include the inability to detect non-viable bacteria, complex handling of 
numerous samples, the slow growth and fastidious nutrition requirements of many 
anaerobes, and the difficult and time-consuming identification of isolates. Drawbacks in 
both DNA–DNA hybridization and QPCR methods include the pre-selection of target 
organisms and potential cross-reactivity with related uncultivable phylotypes, and the 
balance between specific primers separating closely related organisms, yet detecting 
different serotypes and clones of the target bacteria. Additionally, DNA–DNA hybridization 
is semi-quantitative, and sample storage time has been shown to negatively affect the 
bacterial detection and enumeration results (Katsoulis et al. 2005). The adverse effect of 
storage time probably also applies to the other methods. In our study, we chose saliva 
instead of subgingival plaque samples, as it represents more effectively the whole-mouth 
bacterial status, and specimen collection is an easy and non-invasive method. In the 
published QPCR methods (Table 2 in section 1.5.3), the bacteria are predominantly 
detected from subgingival plaque samples and the primer/probe sets are focused on the 
16S rRNA region. However, targeting 16S rRNA may introduce an error due to diversity in 
the copy numbers of the rRNA operon between species and strains. This data may have 
not been available by the time the assays were developed, but should be taken into 
account when calculating the bacterial numbers. Apart from our assays, there are 
currently single-copy gene based assays only for A. actinomycetemcomitans, C. rectus, P. 
gingivalis, and T. forsythia (Yoshida et al. 2003; Morillo et al. 2003; Morillo et al. 2004; 
Saygun et al. 2008). The amplification efficiency and robustness of the existing QPCR 
assays varies and has recently been optimized for 8 periodontitis-associated bacteria by 
Decat et al. who tested multiple primer pairs and three different thermal cyclers (Decat et 
al. 2012).     
   
4.2.2. Association of salivary bacteria levels with CAD (IV) 
  
Four of the developed QPCR assays were further used in analyzing the saliva samples of 
the cohort population consisting of 179 patients with stable CAD  (“Stable CAD”), 166 ACS 
patients (“ACS”), 28 patients with ACS but no CAD (“ACS-like, no CAD”), and 119 patients 
with normal or ≤50% obstructed arteries (“No significant CAD”). The CAD diagnosis was 
verified by coronary angiography. The periodontal diagnosis grouping was based on the 
parameters received from oral examination and digital panoramic tomographs, and 
included five groups: “Healthy”, “Gingivitis”, “Mild periodontitis”, “Moderate–severe 
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periodontitis”, and “Edentulous patients”. The study population is depicted in section 
3.2.2 and the general characteristics are presented in Table 9. The mean age varied among 
the study groups from 59 to 65 years and was highest among “Stable CAD” patients. There 
were no significant differences in body mass index, hypertension, or current smoking 
status between the study groups. However, the serum levels of CRP were high in both 
“ACS” and “ACS-like, no CAD” groups, which was no surprise considering their ACS 
diagnosis with tissue damage. Additionally, the prevalence of dyslipidemia and diabetes 
varied significantly, both being highest (94% and 31%, respectively) in the “Stable CAD” 
group. This might be expected as dyslipidemia and diabetes are considered major risk 
factors for ASVD. Most of the patients had a diagnosis of periodontal disease: 43% had 
mild periodontitis and 29% suffered from moderate–severe periodontitis. Only 12% were 
periodontally healthy. The prevalence of mild periodontitis was relatively low compared to 
the 60% observed in a large Finnish population study (Knuuttila et al. 2008). This 
discrepancy may be explained by the different diagnosis criteria and age distribution. 
 
Table 9. Characteristics of the study population 
 No 
significant 
CAD  
n = 119 
Stable CAD 
n = 179 
ACS 
n = 166 
ACS-like, no 
CAD 
n = 28 
 
 Mean (SD) p-value* 
Age (year)  61.9 (9.0)  65.4 (8.2) 62.8 (9.7) 59.1 (9.8) <0.001 
BMI (kg/m2)  27.7 (5.3)  27.9 (4.6) 28.1 (5.3) 26.4 (4.5) 0.374 
 Median (IQR) p-value† 
Serum hs-CRP (mg/l) 1.91 (3.37) 1.53 (2.63) 5.22 (22.68) 5.19 (17.55) <0.001 
 n (%) p-value‡ 
Gender (men) 58 (49) 133 (74) 119 (72) 8 (29) <0.001 
Current smoking 16 (13) 20 (11) 18 (11) 4 (14) 0.879 
Former smoking 37 (31) 77 (43) 78 (47) 9 (32) 0.046 
Hypertension 70 (59) 126 (71) 104 (63) 14 (50) 0.059 
Dyslipidemia 90 (76) 167 (94) 123 (74) 17 (63) <0.001 
Diabetes 23 (20) 55 (31) 36 (22) 2 (7) 0.010 
*, the One-Way ANOVA; †, the Kruskall–Wallis test; ‡, the Pearson chi-squared test; ACS, acute 
coronary syndrome; BMI, body mass index; CAD, coronary artery disease; hs-CRP, high-sensitivity 
C-reactive protein; IQR, interquartile range; SD, standard deviation. Modified from publication IV.   
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 The detected bacteria frequencies in the study population were 11% for A. 
actinomycetemcomitans, 55% for P. gingivalis, 25% for P. intermedia, and 64% for T. 
forsythia. The prevalences were similar among all periodontal diagnostic groups. However, 
the median levels of P. gingivalis were 36-fold higher among the “Moderate–severe 
periodontitis” group (p = 0.002) compared to 6.6 x 102 GE/ml (IQR 3.8 x 103) among the 
periodontally healthy. The levels of T. forsythia were 11-fold higher in the “Gingivitis” (p = 
0.013), 4-fold in the “Mild periodontitis” (p = 0.025), and 25-fold in the “Moderate–severe 
periodontitis” group (p <0.001) compared to 8.7 x 103 GE/ml (IQR 8.6 x 104) among the 
periodontally healthy. These two bacteria belong to the “Red complex” of periodontal 
disease-associated bacteria, and our results further support their association with the 
disease (Socransky et al. 1998). We also measured the serum levels of antibodies against A. 
actinomycetemcomitans, and despite the bacterium not being associated with periodontal 
disease, the IgA levels were higher in the “Moderate–severe periodontitis” group (p = 
0.009) and the IgG levels in both the “Mild periodontitis” (p = 0.027) and “Moderate–
severe periodontitis” group (p = 0.039) than among the periodontally healthy.  
 The prevalence of the studied bacteria and the median level of total periodontal 
bacterial burden did not differ among cardiac diagnosis groups. However, the median 
levels of A. actinomycetemcomitans were significantly higher among all salivary A. 
actinomycetemcomitans-positive CAD-affected patients and were 6-fold higher among 
“Stable CAD” (p = 0.014), and 3-fold higher among “ACS” (p = 0.044) compared to 2.0x102 
GE/ml (IQR 1.3 x 103) among “No significant CAD” patients. The following logistic 
regression model analysis demonstrated an association between salivary levels of A. 
actinomycetemcomitans and the risk of stable CAD, with an OR of 7.5 (95% CI: 1.6–36, p = 
0.012), and for ACS, with an OR of 4.31 (95% CI: 1.1–18, p = 0.041) per 10-fold increase in 
the bacterial level (Table 10). These results were adjusted for classical CVD risk factors. In 
addition, the serum levels of IgA and IgG against A. actinomycetemcomitans were elevated 
among the “ACS” group (p = 0.003 and 0.057, respectively), and IgA levels associated with 
ACS with an adjusted OR of 3.1 (95% CI: 1.3–7.1, p = 0.006) per 10-fold increase in the 
bacterial level (Table 10). 
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Table 10. The association of the levels of saliva pathogens and serum antibodies with ASVD 
outcome 
  Stable CAD 
n = 179† 
ACS 
n = 166† 
Pathogen  
(log10 GE/ml saliva)* 
  
A. actinomycetem- 
comitans 
Pathogen positivity, n (%) 
Multi-adjusted odds ratios‡ (95% CI) 
p-value 
17 (9.5) 
7.5 (1.6–36) 
0.012 
17 (10.2) 
4.3 (1.1–18) 
0.041 
P. gingivalis 
Pathogen positivity, n (%) 
Multi-adjusted odds ratios‡ (95% CI) 
p-value 
93 (52.0) 
1.0 (0.8–1.3) 
0.884 
96 (57.3) 
1.0 (0.8–1.2) 
0.922 
P. intermedia 
Pathogen positivity, n (%) 
Multi-adjusted odds ratios‡ (95% CI) 
p-value 
50 (28.0) 
1.35 (0.9–2.0) 
0.131 
40 (24.1) 
1.3 (0.9–1.9) 
0.198 
T. forsythia 
Pathogen positivity, n (%) 
Multi-adjusted odds ratios‡ (95% CI) 
p-value 
118 (66.3) 
1.1 (0.8–1.3) 
0.690 
95 (57.6) 
1.0 (0.8–1.3) 
0.836 
Serum antibody 
(log10 EU)† 
 
  
A. actinomycetem- 
comitans IgA 
Multi-adjusted odds ratios‡ (95% CI) 
p-value 
0.9 (0.4–1.8) 
0.683 
3.1 (1.4–7.1) 
0.006 
A. actinomycetem- 
comitans IgG 
Multi-adjusted odds ratios‡ (95% CI) 
p-value 
0.8 (0.4–1.7) 
0.563 
1.94 (0.9–4.2) 
0.097 
*, pathogen-positive patients; †, whole study population; ‡, compared to the “No significant CAD” 
group and adjusted for age, gender, body mass index, smoking, hypertension, dyslipidemia, and 
diabetes; ACS, acute coronary syndrome; CAD, coronary artery disease; CI, confidence interval; EU, 
ELISA units; GE, genomic equivalent. Modified from publication IV. 
 
 Our results demonstrate that the abundance of salivary A. 
actinomycetemcomitans is markedly associated with angiographically verified stable CAD 
and ACS. In addition, the serum levels of IgA against A. actinomycetemcomitans are 
associated with ACS. As listed in Table 3 in section 1.5.4, there are an increasing number 
of studies indicating an association between periodontal pathogens and ASVDs. Apart 
from analyzing subgingival plaque samples, the studies are very heterogeneous regarding 
the methods and results. Our results are in concordance with the findings of Spahr et al. 
demonstrating and an association between the abundance of A. actinomycetemcomitans 
and stable CHD (Spahr et al. 2006). The parallel analysis of our study population using a 
different specimen (saliva vs. subgingival plaque sample) and analysis method (QPCR vs. 
DNA–DNA hybridization), and yet resulting in a similar association of A. 
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actinomycetemcomitans with CAD further supports the relevance of our results (Mäntylä 
et al. 2013). The discrepancies between the results from other studies may derive from 
differences in the methodology, as well as the studied species, specimens, and ASVD 
outcomes. In addition, out of the common set-up, all CAD diagnoses in our study 
population, including the “No significant CAD” diagnosis of control patients, were verified 
by angiography. There have been several studies linking the total bacterial burden with 
the ASVD outcome (Desvarieux et al. 2005; Dogan et al. 2005; Renvert et al. 2006; Spahr 
et al. 2006). Our results, however, failed to show such a relationship. The observed 
association between serum levels of IgA against A. actinomycetemcomitans and ACS are 
supported by earlier findings linking these antibodies with ASVDs (Pussinen et al. 2004; 
Pussinen et al. 2005). The distribution of serum antibody levels against A. 
actinomycetemcomitans across the angiographic groups and different bacteria levels in 
saliva is presented in Figure 6. 
 
 
Figure 6. Distribution of serum antibody levels against A. actinomycetemcomitans across the 
angiographic diagnosis and salivary A. actinomycetemcomitans levels. A) Serum IgA levels. B) 
Serum IgG levels. Salivary A. actinomycetemcomitans level grouping: No Aa, pathogen-negative (n 
= 438); Low Aa, saliva level of A. actinomycetemcomitans <median (n = 27); and High Aa, saliva 
level of A. actinomycetemcomitans ≥median (n = 27).  
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 One limitation of the study is the potential bias away from immobile patients 
because the patients had to be able to attend the oral examination at the Institute of 
Dentistry. Furthermore, the results may be generalizable only to White Caucasians 
because the study population consisted of native Finns only. Another consideration is 
gender. The overall prevalence of women was 35% being lowest (26%) in the “Stable CAD” 
group. Because the cardiac diagnosis was not available at the enrollment time, the age 
and gender differences in CAD diagnostic groups follow the trends observed in the Finnish 
population in general.  
 
4.3. General discussion (I, II, III, IV) 
 
Many common infectious agents have been associated with an increased risk of ASVDs 
(Rosenfeld and Campbell 2011). The present thesis study focused on C. pneumoniae and 
periodontal disease-associated bacteria, especially A. actinomycetemcomitans, and the 
main proatherogenic effects of the infections are summarized in Figure 7. In general, the 
major atherosclerosis-promoting factors are lipid modifications and deposition, with the 
sustaining thrust of chronic inflammation in the arterial wall. The adverse contribution of 
pathogens to atherosclerosis begins with systemic exposure and dissemination of the 
pathogens. The overall increase in the systemic inflammation status comprises innate and 
adaptive immunity responses, including increased levels of acute phase proteins, 
proinflammatory cytokines, and potentially cross-reactive antibodies. In addition to these 
mechanisms, it has been demonstrated that both A. actinomycetemcomitans and C. 
pneumoniae may infect the vascular wall cells, augment foam cell formation, and alter the 
expression of inflammation- and atherosclerosis-related genes, and thereby promote and 
sustain the chronic inflammation in the vascular wall. The results from the thesis study 
broaden the view and show that these infections may also affect atherogenesis via other 
important organs: the liver and adipose tissues. In the experimental mouse model, both 
pathogens induced inflammation and disturbances in lipid homeostasis in the liver, and 
the A. actinomycetemcomitans infection adversely altered the FA distribution in the ATs. 
These changes may promote atherogenesis and the development of steatosis and 
steatohepatitis, especially among dyslipidemic subjects prone to fatty liver. The resolving 
of mechanistic pathways leading to these changes and the potential link with accelerated 
atherosclerosis requires further study. Furthermore, in order to evaluate the clinical 
relevance of these observations, they need to be verified in humans. 
 Another major finding in the thesis study was the association of the salivary levels 
of A. actinomycetemcomitans with ASVD outcomes, which was further supported by the 
serological results. These observations provide more information on the oral status of 
specific cardiac patient groups and emphasize the potential effect of oral health on 
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general health. The depth of host response to bacterial challenge in atherothrombotic 
coronary events probably varies between individuals, and the impact on cardiac health of 
preventive dental treatment and eradication of A. actinomycetemcomitans requires 
further study. In addition, new quantitative methods may help to clarify the dual role of A. 
actinomycetemcomitans as a benign commensal and a harmful pathogen. However, it is 
obvious that good oral health should not only be a target in disease and emergency 
situations, but a lifetime goal. 
 The findings from the thesis study are of common interest because the studied 
pathogens are highly prevalent among the general population and their persistence may 
magnify the overall ASVD risk along with ageing.               
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Figure 7. Schematic representation of the proatherogenic effects of the studied pathogens. The 
dashed arrows represent the hypothetical pathways that are not verified in the thesis study or in 
the literature as such. FA, fatty acid; LPS, lipopolysaccharide; LDL, low density lipoprotein; PUFA, 
polyunsaturated fatty acid; ROS, reactive oxygen species; SFA, saturated fatty acid.  
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5. SUMMARY AND CONCLUSIONS 
 
The aims of the thesis were to investigate the effects of A. actinomycetemcomitans and C. 
pneumoniae infections on the liver and AT lipid homeostasis, as well as the inflammation 
status and AT depot transcriptomes in apoE-deficient mice (I, II); to develop and validate a 
QPCR method to analyze the levels of periodontal disease associated bacteria in saliva 
samples (III); and to determine the association between the salivary levels of these 
bacteria and CAD (IV).  
 Animal studies were conducted in atherosclerosis-susceptible apoE-deficient mice. 
The mice were fed with regular chow and infected intravenously with viable A. 
actinomycetemcomitans and intranasally with viable C. pneumoniae. The recurrent A. 
actinomycetemcomitans infection induced an increase in serum inflammation markers 
and the bacteria were detected from the liver tissue. The infection induced the infiltration 
of innate immunity cells into the liver, up-regulated the relative expression of 
proinflammatory genes, and decreased the levels of hepatic phospholipids. The effect of 
recurrent A. actinomycetemcomitans on AT was partially depot-specific. In inguinal AT, the 
infection promoted the amplification of neutrophil activation-related genes, whereas in 
epididymal AT the genes involved in de novo lipogenesis were up-regulated. In general, 
the infection disturbed AT lipid homeostasis and increased the proportion of SFAs, with a 
parallel decrease in the proportion of PUFAs. The results indicate that recurrent A. 
actinomycetemcomitans infection induces the inflammation status in the liver and alters 
AT FA homeostasis.  
 The hepatic response in mice with acute C. pneumoniae infection associated 
strongly with enhanced inflammation. The pathogen was detected from the lungs and the 
liver and serum inflammation markers were elevated. The relative hepatic expression of 
proinflammatory genes was strongly up-regulated. The lipid alterations promoted the 
inflammatory condition: hepatic phospholipids and PUFAs were decreased and SFAs and 
arachidonic acid were increased. Prolonged infection modified the FA responses observed 
in acute infection. The level of phospholipids remained low and chronic C. pneumoniae 
infection induced microvesicular formations in the liver. The results suggest that C. 
pneumoniae infection is a potent effector in liver inflammation and lipid homeostasis, and 
may thereby promote steatosis. 
 We developed QPCR assays for five periodontal disease-associated bacteria. The 
amplification targets were single-copy genes in the LPS coding region. The assays proved 
to be sensitive and specific and also detected different serotypes. Assay validation was 
conducted in a case-control population comprising 84 periodontally diseased and 84 
periodontally healthy subjects, and the diagnostic accuracy was assessed using ROC 
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analysis. The prevalence and level of periodontal disease-associated pathogens in CAD 
was determined by analyzing saliva samples from a cohort consisting of 179 patients with 
stable CAD, 166 patients with ACS, and 119 patients with no significant CAD. All CAD 
diagnoses were verified by coronary angiography. The median saliva A. 
actinomycetemcomitans levels were significantly higher among pathogen-positive CAD 
and ACS patients compared to the reference group. In an adjusted logistic regression 
model, the increased salivary levels of A. actinomycetemcomitans associated strongly with 
both stable CAD and ACS. In addition, the serum levels of IgA against A. 
actinomycetemcomitans associated with ACS. 
 To conclude, the findings from the study in apoE-deficient mice indicate that A. 
actinomycetemcomitans and C. pneumoniae infections are potent effectors in liver and AT 
metabolism. Recurrent A. actinomycetemcomitans infection induces inflammation in the 
liver and disturbances in the AT FA homeostasis. Acute C. pneumoniae infection induces 
hepatic inflammation and chronic infection contributes to vesicular modifications in liver 
morphology. These changes may promote tissue dysfunction, leading to fatty liver and 
other proatherogenic alterations. The analysis of saliva samples in an angiographically 
diagnosed CAD cohort demonstrated that high salivary levels of A. 
actinomycetemcomitans and the systemic immune response to the pathogen are 
markedly associated with an increased risk of stable CAD. The finding supports the 
association between oral health and general health and underlines the significance of 
good dental health care. 
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